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ABSTRACT  
Structural changes in sensory axons are associated with many peripheral nerve disorders. 
Degenerative loss or excessive sprouting of axons are hallmarks of sensory neuropathies or 
hyperinnervating pain syndromes respectively. While much is known about mechanisms of 
developmental axon growth or regenerative outgrowth following nerve injury, there is little 
information about mechanisms that can induce plasticity in intact adult axons. Lack of model 
systems, where extensive plasticity can be predictably induced under physiological conditions, 
has been a fundamental impediment in studying sensory neuroplasticity mechanisms in adult. 
The female reproductive tract presents a highly tractable model where sensory axons 
cyclically undergo extensive plasticity under the influence of estrogen. In rat, high estrogen 
levels induce reduction in vaginal sensory nerve density, and low estrogen conditions promote 
sprouting leading to hyperinnervation. We used this model to explore potential factors that can 
initiate spontaneous plasticity in intact sensory axons. We found that estrogen downregulates 
expression of Bone Morphogenetic Protein 4 (BMP4) in the vaginal submucosal smooth muscle 
cells which are associated with most innervation in the vagina. Thus under low estrogen 
conditions BMP4 expression increased in the smooth muscle, and the resulting trophic stimulus 
induced sprouting in associated nociceptive sensory axons. Activated Smad1 in nuclei of 
retrogradely labeled dorsal root ganglion neurons innervating the vagina confirmed BMP4 
signaling under low estrogen conditions. When BMP4 was overexpressed in the vaginal 
submucosal smooth muscle by lentiviral transduction, elevated nerve density prevailed even 
under high blood estrogen levels.  
To identify the signaling mechanism by which BMP4 regulates sensory plasticity 
downstream from phospho-Smad1, we used the 50B11 sensory neuronal cell line. Receptor 
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expression and outgrowth responses of the 50B11 cells to neurotrophins and growth factors 
resembled closely that of primary sensory neurons in culture, providing a reliable assay system.  
BMP4 treatment induced upregulation of Inhibitor of DNA binding 2 (Id2), a known 
downstream target of Smad1, in 50B11 cells; and Id2 overexpression induced increased neurite 
outgrowth. However, Id2 knockdown failed to abrogate BMP4-mediated increase of outgrowth 
in primary neurons, suggesting alternative mechanisms. We identified that BMP4 downregulates 
methyl CpG-binding protein 2 (MeCP2), a methylated-DNA binding protein and an epigenetic 
modifier and global transcriptional repressor, which is highly expressed in neurons. MeCP2 
downregulation can prompt a global transcriptional upregulation inducing multiple genes, a 
situation characteristic of axonal growth initiation. Lentiviral knockdown of MeCP2 resulted in 
significant elevation of outgrowth in primary sensory neurons that matched growth induced by 
BMP4. 
Thus, we conclude that BMP4 is a factor capable of inducing plasticity in adult sensory 
axons. Smad1 activation by BMP4 induces sensory outgrowth by downregulating MeCP2 
expression. These findings have significant impact on understanding of genetic and epigenetic 
mechanisms of adult peripheral neuroplasticity. It will also have strong implications in 
considering therapeutic measures in sensory neuroplasticity-associated disorders. The findings 
are particularly important in female pelvic pain syndromes like vulvodynia that are associated 
with excessive nerve sprouting under low estrogen conditions. 
 
 
 
v 
 
 
 
 
 
 
 
 
 
 
DEDICATION 
 
This work is dedicated to my mother Mrs. Bejoyasree Bhattacherjee 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
ACKNOWLEDGEMENTS 
PhD is the highest academic degree that one can earn through formal education. Few 
people have the opportunity to receive this level of training and I consider myself fortunate to 
have been able to fulfill this aspiration. However, such a task would have never been achieved 
without the sustained support and commitment of some very significant people in my personal 
and professional life. I thank them all for standing by and supporting me through this endeavor.   
I must begin by acknowledging the contributions of my mother Mrs. Bejoyasree 
(Moyna) Bhattacherjee, who dedicated most of her life towards bringing up her two children in 
the best possible manner. She chose to be a stay-home mom and always strived to provide her 
sons with the best education, ethics and moral values, even against all odds. I owe much to her 
for whatever is good in me today. The least I could do to acknowledge the contributions and 
sacrifice of this great woman is to dedicate this dissertation to her. 
My elder brother Siddhartha and an extended family of uncles, aunts and cousins have 
always been very supportive of all my academic aspirations and have actively encouraged me in 
pursuing this degree. I sincerely appreciate their love and encouragement. I thank them for 
shouldering my share of responsibilities for all this time that I have been away from home.  
I specially thank Ms. Damayanti Chakraborty for the friendship, support, care and 
collaboration that she has provided me both in life and scientific career so far. She has literally 
been a pillar of strength to sustain me through the course of this degree.  
In training a PhD student, no one plays a bigger role than the mentor. Dr. Peter Smith has 
been excellent in this regard and I consider myself fortunate to have had him as my advisor. The 
extent of independent thinking that he encourages in his students is rare and is one of the major 
foundations of his training strategy. This has immensely helped me develop and mature not only 
vii 
 
my scientific thoughts but also my personality and communication skills (both verbal and 
written). For the training he imparted, I would be indebted to him forever.   
The Smith Lab, which to me is like family, has trained, supported and sustained me 
through these years. I am grateful to all of them, both past and present. Dr. Anuradha 
Chakrabarty, Dr. Dora Agbas and Dr. Wohaib Hasan have been instrumental in my initial 
scientific training and I thank them for their profound technical and intellectual support. I lack 
words to praise the efforts of Dr. Zhaohui Liao and Ms. Elza Kharatyan that has kept Smith 
Lab running smoothly and efficiently for years. I am indebted to them for their assistance and 
technical guidance. My fabulous colleagues and collaborators in the laboratory including Dr. 
Gwenaelle Clarke, Dr. Argenia Doss, Dr. Sarah Tague, Dr. Eva Selfridge and Timothy 
Donohue have also ended up being some of my best friends.  
I thank my collaborators Dr. Michael Soares, Dr. M.A. Karim Rumi, Dr. Hinrich 
Staecker and Dr. Julie Christianson here at KUMC, who have also provided me with valuable 
insights whenever needed. I am grateful to Dr. Ahmet Höke of Johns Hopkins School of 
Medicine, Dr. Miguel Sena-Esteves of the U-Mass General Hospital and Dr. Kazuto Kobayashi 
of Fukushima University (Japan) for sharing resources and reagents essential for this project.  
I am extremely thankful to my committee members Dr. Nancy Berman, Dr. Kenneth 
McCarson, Dr. Hiroshi Nishimune and Dr. Douglas Wright for the guidance they have 
provided me through the course of this degree. I also thank my graduate coordinators Dr. 
Thomas Imig, and Dr. Michael Wolfe who guided me through the hooks and crooks of the 
program from admission to the end. 
I am fortunate to have been a student of the Physiology Department, which has one of 
the largest and most student-friendly graduate programs at KUMC. It provides a wonderful 
viii 
 
training environment for its students. I thank Chairman Dr. Paul Cheney and the administrative 
staff, especially Linda Carr, Shari Standiferd and Jennifer Wallace for making it possible.  
I express my sincere thanks and gratitude to Michelle Winter of the KIDDRC animal 
behavior core. She has meticulously helped me with several animal surgeries and serological 
assays that were essential in many critical experiments of my work.  
I also thank Doug Brownyard, Beth van Luchene, Dr. Don Warn, Jing Huang, Dr. 
Sumedha Gunewardena, Byunggil Yoo, Clarke Bloomer, Phil Shafer and Stan Fernald of the 
KIDDRC core services who have all helped me in different aspects including microarray 
analysis, histology, imaging, image processing, poster printing, computer or software issues. It is 
their cumulative support that makes good research possible for the KIDDRC community.  
I also owe special thanks to Tina Fowler of the KIDDRC. From booking the first air 
ticket that flew me to the interview, to reserving the room for my defense, she has helped me in 
various aspects related to travel, meeting scheduling, ordering etc. without which I couldn’t have 
made through smoothly. 
Last but not least, I thank the KUMC Biomedical Research Training Program for 
funding me as their fellow for two consecutive years, which has partially supported this work.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
TABLE OF CONTENTS 
 
ACCEPTANCE PAGE................................................................................................................... ii 
ABSTRACT...................................................................................................................................iii 
DEDICATION.................................................................................................................................v  
ACKNOWLEDGEMENTS............................................................................................................vi 
TABLE OF CONTENTS................................................................................................................ix  
LIST OF TABLES AND FIGURES..............................................................................................xi  
LIST OF ABBREVIATIONS......................................................................................................xiii  
CHAPTER 1. GENERAL INTRODUCTION................................................................................1  
FIGURES...........................................................................................................................15 
OBJECTIVE AND SPECIFIC AIMS…………………………………………………...19 
CHAPTER 2. BONE MORPHOGENETIC PROTEIN 4 MEDIATES ESTROGEN-
REGULATED SENSORY AXON PLASTICITY IN THE ADULT FEMALE 
REPRODUCTIVE TRACT……………………………………………………………………...20 
ABSTRACT.......................................................................................................................21  
INTRODUCTION.............................................................................................................22  
MATERIALS AND METHODS.......................................................................................24  
RESULTS..........................................................................................................................31  
DISCUSSION....................................................................................................................38 
FIGURES...........................................................................................................................44 
CHAPTER 3. TROPHIC FACTOR AND HORMONAL REGULATION OF NEURITE 
OUTGROWTH IN SENSORY NEURON-LIKE 50B11 CELLS………………………………62 
ABSTRACT......................................................................................................................63 
x 
 
INTRODUCTION.............................................................................................................65 
MATERIALS AND METHODS.......................................................................................67 
RESULTS………………………………………………………………………………..69 
DISCUSSION....................................................................................................................72 
FIGURES...........................................................................................................................77 
CHAPTER 4. MECHANISMS OF BMP4 MEDIATED SENSORY AXON OUTGROWTH…85 
ABSTRACT.......................................................................................................................86 
INTRODUCTION.............................................................................................................87 
MATERIALS AND METHODS.......................................................................................89 
RESULTS………………………………………………………………………………..94 
DISCUSSION..................................................................................................................100 
FIGURES.........................................................................................................................105 
CHAPTER 5. GENERAL DISCUSSION……………………………………………………...123 
REFERENCES............................................................................................................................137 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xi 
 
LIST OF FIGURES 
CHAPTER 1. 
Figure  
1. The female reproductive system of rat………………………………………………………...15 
2. TGFβ and BMP cellular signaling mechanisms………………………………………………17 
 
CHAPTER 2. 
Figure  
1. BMP4 expression and regulation in the adult rat vagina……………………………………...44 
2. BMP receptors are expressed in L6 to S2 sensory neurons…………………………………...46 
3. Vagina-projecting neurons express BMP4 receptors………………………………………….48 
4. Target-derived BMP4 promotes sensory neurite outgrowth…………………………………..50 
5. Neurite outgrowth in co-cultures is downregulated by estrogen and rescued by exogenous 
BMP4…………………………………………………………………………………………….52 
6. pSmad1 expression in dorsal root ganglion neurons is reduced after estrogen  
administration……………………………………………………………………………………54 
7. Lentiviral injection regulates BMP4 expression in vaginal smooth muscle…………………..56 
8. BMP4 overexpression preserves vaginal innervation at high estrogen……………………….58 
9. BMP4 over-expression selectively affects sensory innervation density………………………60 
 
CHAPTER 3. 
Figure  
1. Differentiated 50B11 cells show cytoplasmic proteins characteristic of DRG neurons………77 
xii 
 
2. Expression of growth factor receptors by 50B11 cells………………………………………..79 
3. Both neurotrophic and hormonal factors increase total neurite length in differentiated  
50B11 cells……………………………………………………………………………………….81 
4. Neurotrophins and hormones increase length of the longest neurite in differentiated  
50B11 cells……………………………………………………………………………….………83 
 
CHAPTER 4. 
Figure  
1. Multiple growth factors induce Id2 upregulation in 50B11 cells……………………………105 
2. Id2 overexpression induced increased neurite outgrowth in 50B11 cells……………………107 
3. Id2 knockdown in using lentiviral vector…………………………………………...……….109 
4. Id2 knockdown downregulated neurite outgrowth in primary DRG neurons……………….111 
5. Quantification of neurite outgrowth in Id2 knock down primary DRG neurons in vitro 
following BMP4 treatment……………………………………………………………………..113 
6. MeCP2 is strongly expressed in adult DRG neurons………………………………….……..115 
7. BMP4 downregulates MeCP2 expression in primary sensory neurons……………………...117 
8. Lentiviral shRNA delivery effectively knocks down MeCP2 in primary sensory neurons of 
DRG in culture………………………………………………………………………………….119 
9. MeCP2 knockdown induces robust increase of neurite outgrowth in primary DRG 
neurons.........................................................................................................................................121 
 
 
 
 
 
xiii 
 
LIST OF ABBREVIATIONS (used extensively in this document) 
ANGII – Angiotensin II 
AT2 – Angiotensin II receptor type 2 
BDNF – Brain Derived Neurotrophic Factor 
BMP- Bone Morphogenetic Protein  
BMP4 – Bone Morphogenetic Protein 4 
CFA – Complete Freund’s Adjuvant 
CGRP – Calcitonin Gene Related Peptide 
CMV – Cytomegalovirus 
CNS – Central Nervous System 
DRG – Dorsal Root Ganglia 
EGFP – Enhanced Green Fluorescent Protein 
FGF – Fibroblast Growth Factor 
FRT – Female Reproductive Tract 
GDNF – Glial cell line Derived Neurotrophic Factor 
GFP – Green Fluorescent Protein 
HDAC – Histone Deacetylase  
HLH – Helix-loop-Helix (protein/transcription factor) 
bHLH – Basic Helix-loop-Helix (protein/transcription factor) 
ir – immunoreactive or immunoreactivity 
Id – Inhibitor of DNA (also called Inhibitor of Differentiation) 
Id2 – Inhibitor of DNA 2 
MeCP2 – Methyl CpG-binding Protein 2 
NGF – Nerve Growth Factor 
PGP9.5 – Protein Gene Product 9.5 
PNS –Peripheral Nervous System 
xiv 
 
SP – Substance P 
TF – Transcription Factor 
TGFβ – Transformaing Growth Factor Beta 
TH – Tyrosin Hydroxylase 
VAChT – Vesicular Acetylcholine Transporter  
VEGF- Vascular Endothelial Growth Factor 
1 
 
 
 
 
 
 
 
 
Chapter1. GENERAL INTRODUCTION 
 
 
 
 
 
 
 
 
 
2 
 
Background  
The peripheral nervous system (PNS) retains significant potential for structural plasticity 
even in the adult. Throughout life, changes in sensory and autonomic axon density and 
distribution occur in several organs and tissue microenvironments. While triggered mostly by 
functional needs in physiological state, such changes are also signature of forthcoming 
pathological conditions. Pathologies are either associated with degenerative loss of axons as seen 
in various neurpopathies, or with abnormal sprouting of axons causing tissue hyperinnervation, 
as most commonly observed in various pain syndromes. This is unlike the central nervous 
system (CNS), where most connections are hardwired early in life, with little scope of 
modification or regeneration in the adult. Thus, studying fundamental mechanisms of adult 
peripheral axon plasticity is crucial for understanding the development, progress and potential 
remedies of a wide range of PNS disorders. 
A major impediment in studying plasticity of the adult PNS has been the lack of suitable 
animal models where plasticity can be induced in a predictable and possibly reversible fashion, 
under physiological conditions and studied through the course of its development. This would 
provide a more thorough understanding of the mechanism that can help in protecting, preserving 
and rejuvenating innervation to even prevent onset of pathology. In most diseases structural 
changes in axons occur over a protracted period of time and the initiating factors often disappear 
by the time the symptoms manifest. While such changes initiate in intact adult axons, most of our 
current understanding of adult neuroplasticity is reliant upon nerve injury models.  
In the female reproductive tract, nerve density changes rapidly, robustly and reversibly 
with changes in blood levels of estrogen, cyclically throughout reproductive life (Ting et al., 
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2004). Dysregulation of nerve density can cause vulvo-vaginal hyperinnervation resulting in 
pelvic pain syndromes, a set of disorders that prevail in nearly 16% women in the United States 
alone and cost upto $1.5 billion annually, with no effective cure known (Masheb et al., 2000; 
Goldstein and Burrows, 2008). In the present study we explored this highly tractable model in rat 
to find how plasticity is spontaneously induced in mature sensory axons of the vagina in absence 
of any injury, under physiological conditions.  
Peripheral neuroplasticity and disease 
Several peripheral neurological disorders are associated with change in the local density 
of axon terminals (number of terminals per unit area) leading to either hypo- or hyper-
innervation. Sensory deficits due to degenerative axonal loss induced by numerous conditions 
including diabetes, chemotherapeutic drugs, alcoholism, injury or idiopathic conditions are 
common examples of hypo-innervation disorders (Walsh and McLeod, 1970; Behse et al., 1977; 
McLeod, 1995; Jaggi and Singh, 2012).  
Hyperinnervation, on the other hand, is mainly associated with disorders of hyperactivity 
or hypersensitivity. Sympathetic hyperinnervation of the heart induced by nerve growth factor 
(NGF) release from infiltrating immune cells following myocardial infarction leads to 
subsequent hyperexcitability and increased risk of congestive heart failure (Hasan et al., 2006). 
Sensory hyperinnervation induced by systemic disorders like vitamin D deficiency leads to 
chronic musculoskeletal pain (Tague et al., 2011). Increased density of sensory nociceptive 
fibers is also a hallmark of several chronic and acute painful conditions. Diseases like Achilles 
tendonitis, chronic knee pain, degenerative disc disease, appendicitis, endometriosis, mastodynia, 
vulvodynia etc. are characterized by marked nociceptive hyperinnervation at the site of pain and 
4 
 
hypersensitivity (Di Sebastiano et al., 1995; Brown et al., 1997; Sanchis-Alfonso and Rosello-
Sastre, 2000; Tympanidis et al., 2003; Gopinath et al., 2005; Schubert et al., 2005; Sandkuhler, 
2009). In standard rodent models of inflammatory pain like planter injection of carrageenan or 
complete Freund’s adjuvant, marked hyperinnervation at the injection site was observed which 
associated with significantly reduced pain thresholds even days after the injection (Chakrabarty 
et al., 2011). The higher number of branches might contribute not only to summation of locally 
evoked depolarization potentials but also to elevated release of pro-inflammatory neuropeptides 
from peptidergic axons seen at high density at these sites. However, factors that can induce 
plasticity in an adult uninjured axon are poorly defined and mechanisms behind most of these 
neuroplasticity associated disorders remain unknown. 
Estrogen and neuroplasticity 
Estrogen has profound effects on the structure and function of the nervous system. 
Initially it was believed that estrogen affects only hypothalamus and parts of the brain associated 
with reproductive function or behavior (Harris and Naftolin, 1970; Perez et al., 1990); but 
subsequently it was shown to affect several other brain regions including hippocampus, cerebral 
cortex, preoptic area, dorsal raphe, nucleus accumbens, limbic system and many others (Patchev 
et al., 1995; McEwen, 2002). Indeed, estrogen receptors express extensively in neurons of both 
the CNS and PNS (Shughrue et al., 1997; Patrone et al., 1999; Mitra et al., 2003). In the CNS 
estrogen induces structural plasticity like dendritic growth in some parts and functional plasticity 
like potentiation or receptor expression in some others (McEwen et al., 2001; Sakamoto et al., 
2003; Cooke and Woolley, 2005; Cardona-Rossinyol et al., 2013). Beyond functional roles, a 
prominent neuroprotective role of estrogen has also unveiled over the years (Alonso and 
Gonzalez, 2012; Shao et al., 2012; Cardona-Rossinyol et al., 2013).  
5 
 
The effect of estrogen in the PNS was described subsequently. In dissociated culture, 
sensory neurons of the DRG express ERα and respond to estrogen by increased neurite 
outgrowth (Blacklock et al., 2005; Chakrabarty et al., 2008). In vivo CGRP innervation 
associated with arterioles undergoes increased sprouting with increase in estrogen (Blacklock et 
al., 2004). CGRP innervation of the mammary gland also increases with rise of estrogen levels 
(Blacklock and Smith, 2004). Interestingly, in the periphery, interaction of the axon with the 
target also plays a vital role in plasticity decisions and innervation is crafted according to the 
target’s functional need. Often the target can be estrogen responsive and plasticity could be 
driven predominantly by the effect of estrogen on the target. In the reproductive tract estrogen 
induces changes in secretory properties of the target tissue to induce plasticity of the innervating 
axons. In the uterus effect of estrogen on the myometrium lowers density of associated 
sympathetic innervation (Zoubina and Smith, 2000; Zoubina et al., 2001). In the vagina lowering 
levels of estrogen alters trophic properties of submucosal smooth muscle to induce sprouting of 
the sensory nociceptive and autonomic nerve fibers (Ting et al., 2004). In postmenopausal 
women, vaginal innervation density may increase due to low levels of estrogen. Local vaginal 
application of topical estrogen can reduce this innervation density (Griebling et al., 2011), 
suggesting that a local effect of estrogen on target tissue induces neuroplasticity. 
The rodent reproductive tract as a model for study of neuroplasticity 
The female reproductive tract is a highly estrogen-responsive organ. It undergoes 
extensive structural and functional changes under the influence of reproductive steroid 
hormones, particularly estrogen, cyclically through the reproductive life. With high estrogen 
levels there is increase in tissue mass, circulation, secretion and other vital functional properties 
of the reproductive tract. Not surprisingly, this initiates change in the innervation of the tissue on 
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both structural and functional demand. The female reproductive tract therefore provides a very 
effective model for studying target-nerve interaction leading to active neuroplasticity under 
physiological conditions in the adult peripheral nervous system. 
 In rodents, the female reproductive tract is comprised of the uteri, the cervix and the 
vagina. The two uterine horns begin from the oviducts and connect at the cervix that leads to the 
vagina (which opens to the exterior through the vulva) (Fig. 1). Each segment of the tract has 
unique histological characteristics besides their distinct functional role. The sensory innervation 
to the different parts of the tract comes from the thoraco-lumber (for uterus) and lumbo-sacral 
(for cervix and vagina) dorsal root ganglia. The sympathetic nerve supply comes from the 
equivalent levels of the sympathetic paravertebral ganglia; and the parasympathetic supply 
comes from the paravertebral and paracervical ganglia. 
 With increased estrogen levels there is rapid degeneration of sympathetic nerves in the 
uterus, which is reversed with decreased estrogen levels; no other nerve populations undergo 
change (Zoubina and Smith, 2000; Zoubina et al., 2001; Latini et al., 2008). In cervix, there is no 
change of innervation with changing levels of estrogen. While in the vagina, a fall in estrogen 
levels induces sprouting of sensory nociceptive, sympathetic and parasympathetic nerve fibers. 
Ovariectomy, which removes most systemic estrogen and simulates surgical menopause, induces 
marked vaginal hyperinnervation and hypersensitivity. However, this is reduced to normal when 
estrogen is supplemented exogenously by a subcutaneous slow-releasing pellet implant (Berkley 
et al., 1993; Ting et al., 2004). Although the entire female reproductive tract is highly estrogen 
responsive, these observations indicate unique target-nerve interactions at different levels, driven 
perhaps by distinct functional needs and achieved via unique estrogen response of the local 
microenvironment.  
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 The change in sympathetic innervation of the uterus has been explained by changes in 
levels of BDNF (brain derived neurotrophic factor), neurotrimin and semaphorin 3F (matrix 
proteins) in the target uterine myometrium (smooth muscle layer of uterus) under the influence 
of estrogen (Krizsan-Agbas et al., 2003; Krizsan-Agbas et al., 2008; Richeri et al., 2011). 
However, these mechanisms fail to explain neuroplasticity induced in the vagina where sensory 
nociceptive fibers are affected, unlike in the uterus. (Ting et al., 2004).  
The sensory innervation of the vagina majorly comprise of unmyelinated sensory 
nociceptive fibers that originate mainly from small-medium diameter neurons of the L6-S1 DRG 
(Berkley et al., 1993). The vaginal tissue consists of three main layers from outside inwards: i) 
the outer serous tissue comprising mainly of collagen, matrix and connective tissue cells, ii) the 
middle muscular layer (often referred to as the submucosa) comprising of circular smooth 
muscle and iii) the inner layer of a thick pseudo-stratified epithelium (often referred to as the 
mucosa) that lines the inner lumen. Sensory innervation in the tissue is primarily associated with 
the submucous smooth muscle layer. There is hardly any innervation to the epithelium.  
While vulvo-vaginal hyperinnervation under low estrogen conditions has been associated 
with various pelvic pain syndromes in women, mechanisms stimulating nociceptor sprouting in 
the vagina and several other pain syndromes remain unknown. In this study we adopted vaginal 
neuroplasticity in rat as a model to identify potential factors and mechanisms capable of inducing 
outgrowth in adult sensory axons.  
 Female Pelvic Pain Syndromes: association with estrogen and hyperinnervation 
Pelvic pain syndromes are a set of disorders in women characterized by acute or chronic 
pain in pelvic, vaginal and vulvar areas. Vulvodynia and vulvar vestibulitis (also known as 
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vestibulodynia or provoked vulvodynia) are two most prevalent forms of the disease (Bachmann 
et al., 2006; Goldstein and Burrows, 2008). These pain syndromes manifest through multiple 
symptoms including intense pain in the vulvo-vaginal areas, burning, itching, rawness, erythema, 
hyperalgesia, persistent discomfort and dyspareunia (painful intercourse) that can persist for days 
(Masheb et al., 2000; Haefner et al., 2005).  
Vulvodynia (also known as generalized/dysesthetic/ essential/idiopathic vulvodynia) is 
characterized by spontaneous pain symptoms occurring at multiple locations or all over the 
vulvo-vaginal region Symptoms erupt suddenly without any provocation and can last for days. 
This syndrome is more prevalent peri- or post-menopausal women and is associated with low 
blood estrogen levels.(Bachmann and Rosen, 2006; Bachmann et al., 2006; Reed, 2006; 
Goldstein and Burrows, 2008).  
Vulvar vestibulitis (also known as vestibulodynia) on the other hand, is a form of 
‘provoked’ vulvodynia where symptoms are restricted primarily around the vulvar vestibule and 
can be induced severely by even slight touch, pressure or friction. This form of vulvodynia is 
more prevalent in younger women and is associated with estrogen receptor dysfunction, which is 
can be idiopathic or often resulting from high progesterone (birth control pills) usage in early 
life. In all its forms vulvodynia results in severe physical & mental distress, a compromised 
sexual life and an immense loss of productivity (Eva et al., 2003; Bohm-Starke et al., 2004; 
Haefner et al., 2005; Bachmann et al., 2006; Reed, 2006; Goldstein and Burrows, 2008).   
The prevalence of female pelvic pain syndromes is high with about 16% of the adult 
female population affected by some form or the other, in the United States alone. It is a persistent 
health issue with no effective cure (Harlow and Stewart, 2003; Haefner et al., 2005). The disease 
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mechanism being unknown management has relied mostly on physical therapy, tricyclic 
antidepressants, personal counseling or even local application of gabapentin (Ben-David and 
Friedman, 1999; Goldstein et al., 2005). However, these offer only limited benefits. Hormone 
replacement therapy to replenish estrogen in post-menopausal women could provide some relief 
but it has a host of associated risks and side effects.  
Finally, study of biopsy samples from patients of vulvar vestibulitis revealed remarkable 
sensory nociceptive hyper-innervation at the sites of pain (Bohm-Starke et al., 1999; Tympanidis 
et al., 2003). Surgical excision of these hyperinnervated portions of the vestibule resulted in 
alleviation of pain (Goetsch, 1996). Related models in rodents showed that ovariectomy 
(simulating menopause surgically) can induce marked vaginal hyperalgesia and hyperinnervation 
in rat. Both pain and hyperinnervation subsided with estrogen supplementation (Bradshaw et al., 
1999; Bradshaw and Berkley, 2002; Ting et al., 2004). Thus pelvic pain syndromes are now 
believed to be associated with hyperinnervation due to impaired estrogen signaling but what 
induces neuroplasticity under low estrogen conditions remain unknown. It appears that change in 
estrogen levels alters the trophic environment of the vagina inducing nerve sprouting. While 
several trophic factors can be present, Bone Morphogenetic Protein 4 is an important member 
intrinsic to the vaginal tissue that critical not only in the early morphogenesis but also in final 
maturation of the organ in adult (Cai, 2009). 
Bone Morphogenetic Protein signaling  
Bone Morphogenetic Proteins or BMPs are members of the Transforming Growth Factor 
beta (TGFβ) family of proteins that associate with functions like growth, maturation, 
proliferation, differentiation and cellular migration. Initially discovered for their role in bone 
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formation, BMPs have wide range of effects on multiple organs and cell types, affecting varied 
aspects of tissue development from embryogenesis to tumorogenesis. Hence they have been 
referred (classified) time to time as morphogens, growth factors or cytokines, in context specific 
manner (Dimitriou and Giannoudis, 2005; Gazzerro and Canalis, 2006).  
BMPs are small secreted proteins, acting usually as dimers, expressed as early as 
embryonic gastrulation and exert their effects locally through paracrine/autocrine mechanisms. 
About 20 different BMP members have been identified and characterized over time. BMPs act 
through cell surface serine/threonine kinase receptor heterodimers usually comprising the type I 
(which could be BMPRIA or BMPRIB variant) and type II (BMPRII). BMP ligands bind to the 
type II receptor which then heterodimerizes with and phosphorylates the type I receptor subunit 
inducing the kinase activity of its cytoplasmic domain (Nohe et al., 2004; Gazzerro and Canalis, 
2006). This domain phosphorylates cytoplasmic proteins called Smads that carry the message to 
the nucleus to regulate gene expression (Miyazono et al., 2010) (Fig. 2).  
 Smad-s are a family of proteins involved in transcriptional regulation, especially 
downstream of TGFβ signals (Miyazawa et al., 2002) (Fig. 2). These ~500 amino acid proteins 
are conserved through evolution and derive their name on the basis of homology with Sma and 
Mad proteins respectively in C. elegans and Drosophila. Smads have two conserved domains 
called the mad homology (MH) domains: MH1 at amino terminal and MH2 at carboxy terminal. 
MH1 can bind DNA directly, while MH2 plays the role of binding other proteins essential for 
gene regulation (Massague et al., 2005). In mammals there are 8 different Smads. Of these 
Smad1, 5 and 8 (called R-Smads) propagate signal from the membrane in response to BMPs.  
They are phosphorylated by the kinase activity of the Type I receptor that initiates binding to 
Smad4 (called Co-Smad) in cytoplasm and the complex is transported to the nucleus 
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(independent of importins, by direct interaction with nucleoporins) (Miyazono, 1999; Massague 
et al., 2005) (Fig. 2). In the nucleus, the complex can directly bind DNA or interact with several 
transcription factors (eg. Runx-2, Menin, Yin Yang1, Hoxc8 etc.) or act in association with other 
transcriptional coactivators/repressors (eg. CPB/SnoN) (Miyazono, 1999; Nohe et al., 2004; 
Massague et al., 2005). While Smad1/5/8 exclusively transduce BMP signals, other TGFβ 
members signal through Smad2 and Smad3 but share the common Co-Smad (Smad4). Two other 
Smads, Smad6 and 7, known as I-Smads or inhibitory Smads help maintain dynamic equilibrium 
when required, through negative feedback loops. Phosphorylation and nuclear migration of R-
Smads is a classic evidence/marker of canonical BMP signal transduction. In the nucleus the 
Smad complex themselves regulate transcription and also induce other transcription factors that 
regulate gene expression (Miyazono, 1999; Miyazawa et al., 2002; Nohe et al., 2004). 
BMP4: Importance and early effects on peripheral nervous system 
The functions of BMPs in development are indispensable. BMP4 is one of the most 
important members of the family which is needed as early as embryonic gastrulation. The ~116 
amino acid protein is secreted from the extraembryonic tissues and in conjunction with nodal 
signaling induces the formation of the primitive streak (Gazzerro and Canalis, 2006). It is 
eventually secreted from the dorsal notochord and helps establish dorso-ventral axis acting in 
concert with sonic hedgehog secreted from the ventral notochord. Gene knockouts in mouse for 
most BMPs are lethal either in utero or right after birth. For example, BMP2 knockouts are lost 
at E7.5-10.5 (amnion/chorion and cardiac malformations) and BMP7 knockout is lethal at  
(skeletal patterning defect: ribs, skull and hind limbs). However, one of the strongest effects is 
induced by the BMP4 knockout and embryos are lost as early as E6.5-9.5 with no mesoderm 
development (Dimitriou and Giannoudis, 2005; Gazzerro and Canalis, 2006).  
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BMP4 acts as one of the major BMPs regulating events in nervous system from early 
development inducing neural crest migration, phenotype specification, target innervation and 
several other functions. Interplay of noggin (an endogenous peptide BMP antagonist) and BMP4 
produced in diametrically opposite sources generates a gradient of BMP4 in the dorsal tube that 
triggers the delamination of the neural crest (Sela-Donenfeld and Kalcheim, 1999a; Gazzerro and 
Canalis, 2006). Neural crest migration ultimately leads to the formation of the cranial ganglia, 
dorsal root ganglia, the sympathetic ganglia, the parasympathetic and enteric nervous system 
(Burian et al., 2000). In the developing peripheral ganglia BMP4 plays a continued role in 
maturation, target innervation and phenotype specification. It is observed that target derived 
BMP4 is necessary for the trigeminal sensory ganglia neurons to form specific face maps (Hodge 
et al., 2007). Target derived BMP4 is also obligatory for the formation of cutaneous sensory 
nerves (Honig et al., 2005). In the chick hind limb exogenous BMP4 alone was sufficient to 
generate cutaneous innervation after removal of ectoderm which supplies an ensemble of 
additional positive and repulsive cues besides BMP4, under normal conditions (Honig et al., 
2005).  
BMP signaling also contributes to phenotype specification of peripheral sensory neurons. 
Skin-derived BMP signal is essential for peptidergic neurons of the DRG to initiate expression of 
CGRP and SP (Hall et al., 1997). Cutaneous innervation in the rat hind limb arrives around E16-
17 (Mirnics and Koerber, 1995) and neuropeptides first appear in the innervating lumbar DRG 
neurons around E17-18 (Kessler and Black, 1981; Kudo and Yamada, 1985; Marti et al., 1987). . 
Furthermore, stimulation of early embryonic neurons with BMP4 in vitro induces expression of 
these neuropeptides (Hall et al., 1997; Hall et al., 2002). Thus BMP4 has exquisite effects on the 
peripheral sensory innervation from embryo through neonate, but little is known about its 
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potential influence on the adult PNS. Evidence in brain indicate that BMP4 could still be an 
active regulator of nerve growth and plasticity in the adult (Mikawa et al., 2006). Although 
multiple target tissues continue expressing BMP4 in the adult organism and many coincide with 
sites of active neuroplasticity, plausible regulatory effects of BMP4 on peripheral nerves remain 
to be investigated (Cao et al., 2000; Hasan et al., 2006; Chen et al., 2010; Pachori et al., 2010; 
Scott and Fryer, 2012; Scott et al., 2013).  
Initiating outgrowth in adult peripheral neurons requires transcriptional reactivation 
Axonal growth is a combinatorial outcome of various subcellular activities like signal 
processing, protein synthesis, axonal protein transport, dynamic cytoskeletal changes and many 
others. In the final stages of development, as a neuron matures terminally and its axon contacts 
the target, these active processes involved in outgrowth are shut down (Chen et al., 2007b). 
Much of this is achieved by permanent alterations in gene expression. It is therefore believed that 
to bring an adult neuron out of its quiescence and rekindle outgrowth, a specific transcriptional 
reactivation program is essential.  
Models of axonal injury in the adult peripheral sensory neurons provide evidence of 
massive transcriptional reactivation (Smith and Skene, 1997; Goldberg, 2003). Inflicting a 
mechanical injury induces upregulation of a host of factors in the peripheral neurons starting as 
early as 24h and continuing beyond 7days (Mechaly et al., 2006; Szpara et al., 2007). A 
significant percentage of genes induced overlap with those active during developmental axon 
growth (Mechaly et al., 2006; Patodia and Raivich, 2012a). A majority of these include 
transcription factors, for example, the activating transcription factor 3 (ATF3), the AP-1 family 
of transcription factors (eg. c-Jun, Jun D), cAMP response element binding protein (CREB), 
14 
 
signal transducer and activator activator of transcription (STAT3), Oct6, Sox11, SnoN, E47, to 
name a few. In fact at least 39 transcription factors (of 26 families) have been implicated in 
response to axonal injury (Moore and Goldberg, 2011; Patodia and Raivich, 2012a). In vivo 
knockouts of most of these transcription factors dramatically impair regeneration indicating their 
critical requirement for outgrowth (Patodia and Raivich, 2012b). Cumulatively, they orchestrate 
signaling and gene expression to direct subcellular events towards successful outgrowth. 
While these findings substantiate the necessity of a large-scale transcriptional reactivation 
for neurite outgrowth, it is unknown how such activation occurs when outgrowth initiates in 
undamaged axons (especially under physiological conditions). Few of the signaling triggers 
activated by the stress of injury (like cytokines, immunogens, growth factors etc.) are likely to be 
available in absence of injury. What mechanism does the neuron rely upon to drive the multitude 
of subcellular processes necessary? The present study attempts to answer parts of this question 
by investigating physiological plasticity in the female reproductive tract. The findings might 
have strong implications not only in understanding plasticity mechanisms in mature axons, but 
also in therapeutic design for peripheral nerve disorders associated with abnormal loss or gain of 
axons. 
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Figure 1. The female reproductive system of rat. A. Photograph of a gross dissected and isolated 
female urino-genital system from an adult (6-8 weeks old rat). B. Line drawing representation of 
structures in A delineating the individual organs. Labels indicate the different parts of the 
reproductive tract including the uterine horns, uterine body and the vagina. Cervix is located 
under the urinary bladder. (Picture adapted and modified from: Dept. of Environmental Health 
and Safety, University of Cincinnati, ehs.uc.edu) 
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Figure 2. TGFβ and BMP cellular signaling mechanisms. BMP family of proteins act by binding 
the cell surface receptor heterodimer of Type I and Type II receptors (also known as BMPR1 and 
BMPR2). Receptor activation leads to phosphorylation of Smad1/5/8 proteins by the cytoplasmic 
tail of BMPR1 which complexes with Smad4 and travels to the nucleus to bind Smad-binding 
domains of promoters in DNA to regulate gene expression. TGFβ works through a similar 
mechanism but with different set of receptors (TGFβRI and II) and different Smads (Smad2 and 
3) but the same co-Smad, Smad4. TGFβ might also elicit p38 MAP kinase signals downstream 
from the receptor. Smad6 and 7 are inhibitory Smads that help balance signaling through 
feedback loops of inhibition when necessary. (Adapted and modified from: www.humpath.com) 
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Objective and Specific Aims: 
Structural plasticity of mature sensory axons is associated with several peripheral nervous system 
disorders. Most of our knowledge of sensory axonal plasticity in adult is derived from study of 
nerve injury models, but mechanisms capable of inducing plasticity in intact axons remain 
largely unknown. Understanding of these mechanisms is crucial in conceiving curative 
approaches for several peripheral neuropathies associated with degenerative axon loss, as well as 
hyperinnervating pain syndromes. The broad objective of the present study was to explore 
mechanisms of structural plasticity in the intact sensory axons of the adult peripheral nervous 
system. In the rat vaginal tract, sensory axon density changes spontaneously under physiological 
conditions, throughout adult reproductive life with change in blood estrogen levels; low estrogen 
levels stimulate sensory axonal sprouting. We adopted this model system to study neuroplasticity 
mechanisms of intact sensory axons. We approached the problem through the following three 
specific aims: 
Aim 1: Identifying potential target derived factors in vagina that regulate sensory axon 
plasticity. 
Aim 2: Identifying a suitable high throughput assay system for studying signaling 
mechanisms in sensory neurons. 
Aim 3: Identifying the downstream signaling mechanism that induces axon plasticity in adult 
sensory neurons. 
The findings related to Specific Aims 1, 2 and 3 are reported in Chapters 2, 3 and 4 respectively.  
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Chapter 2. Bone Morphogenetic Protein 4 Mediates Estrogen-Regulated Sensory Axon 
Plasticity in the Adult Female Reproductive Tract 
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ABSTRACT 
Peripheral axons are structurally plastic even in the adult, and altered axon density is 
implicated in many disorders and pain syndromes. However, mechanisms responsible for 
peripheral axon remodeling are poorly understood. Physiological plasticity is characteristic of the 
female reproductive tract: vaginal sensory innervation density is low under high estrogen 
conditions such as term pregnancy, while density is high in low-estrogen conditions such as 
menopause. We exploited this system in rats to identify factors responsible for adult peripheral 
neuroplasticity. Calcitonin gene-related peptide-immunoreactive sensory innervation is 
distributed primarily within the vaginal submucosa.  Submucosal smooth muscle cells express 
Bone Morphogenetic Protein 4 (BMP4). With low estrogen, BMP4 expression was elevated 
indicating negative regulation by this hormone. Vaginal smooth muscle cells induced robust 
neurite outgrowth by co-cultured dorsal root ganglion neurons, which was prevented by 
neutralizing BMP4 with noggin or anti-BMP4. Estrogen also prevented axon outgrowth, and this 
was reversed by exogenous BMP4.  Nuclear accumulation of phosphorylated Smad1, a primary 
transcription factor for BMP4 signaling, was high in vagina-projecting sensory neurons 
following ovariectomy, and reduced by estrogen. BMP4 regulation of innervation was confirmed 
in vivo using lentiviral transduction to overexpress BMP4 in an estrogen-independent manner.  
Submucosal regions with high virally induced BMP4 expression had high innervation density 
despite elevated estrogen.  These findings show that BMP4, an important factor in early nervous 
system development and regeneration after injury, is a critical mediator of adult physiological 
plasticity as well.  Altered BMP4 expression may therefore contribute to sensory 
hyperinnervation, a hallmark of several pain disorders including vulvodynia.  
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INTRODUCTION 
Peripheral target organs can undergo significant changes in innervation associated with 
both adaptive and maladaptive events. Certain pathophysiological conditions such as 
neuropathies have long been associated with reductions in axon numbers (Lauria et al., 2005), 
while more recent studies show that increased innervation density (hyperinnervation) can also 
contribute to pathological conditions such as sudden cardiac death after myocardial ischemia 
(Cao et al., 2000; Hasan et al., 2006), musculo-skeletal pain in vitamin D deficiency (Tague et 
al., 2011) and inflammatory pain (Bohm-Starke et al., 1999; Chakrabarty et al., 2011).  These 
findings underscore the malleability of peripheral axons under pathophysiological conditions in 
the adult organism.   
Changes in peripheral innervation also occur physiologically in the mature organism as it 
adapts to demands incurred as a result of normal activities.  This is particularly true for targets 
that must make substantial and sometimes rapid adjustments in structure and function.  Perhaps 
some of the most vivid examples are those associated with female reproductive functions.  For 
example, the uterus undergoes rapid denervation coincident with the sexually receptive phase of 
the estrous cycle, which is thought to be important in providing an environment conducive to 
implantation of the conceptus.  Innervation is again depleted during pregnancy, contributing to 
uterine quiescence prior to hormonally regulated parturition (Latini et al., 2008), followed by 
reinnervation (Brauer, 2008) .  Similarly, vaginal innervation is reduced at term pregnancy, 
which may facilitate delivery by diminishing vaginal smooth muscle tone and promoting 
maternal well-being by reducing numbers of local pain-sensing terminals (Liao and Smith, 
2011).  
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Estrogen appears to be a dominant factor driving reproductive tract neuroplasticity. 
Vaginal innervation by presumptive nociceptor axons containing calcitonin gene-related peptide 
(CGRP)-immunoreactivity (-ir) is increased in rats under low estrogen conditions following 
ovariectomy (an animal model of menopause), and reduced by elevating serum estrogen by 
exogenous administration of 17 β-estradiol (Ting et al., 2004; Liao and Smith, 2011). In humans, 
systemic estrogen replacement therapy also reduces vaginal innervation density in post-
menopausal women, and this effect is more robust when estrogen is applied topically (Griebling 
et al., 2011) implying a direct effect on vaginal tissue.  It therefore appears that declining 
estrogen levels are associated with increased outgrowth by vaginal nociceptor axons. 
Axon outgrowth in the adult is believed to require reactivation of certain transcriptional 
programs that are typically quiescent in mature neurons.  For example, the transcription factor 
Smad1 is normally expressed at very low levels in intact dorsal root ganglion sensory neurons, 
but is markedly upregulated in association with regeneration after axonal injury (Zou et al., 
2009). Smad1 is regulated by Bone Morphogenetic Protein 4 (BMP4), a member of the TGFβ 
superfamily of cytokines/morphogens (Miyazono et al., 2010).  A possible role for the 
BMP4/Smad1 signaling pathway in reproductive tract axon remodeling is supported by reports 
that BMP4 is synthesized by vaginal tissues (Cai, 2009) and negatively regulated by estrogen 
(Chen et al., 2009). In the present study, we investigated whether BMP4 mediates estrogen-
driven plasticity of peripheral sensory innervation. 
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MATERIALS AND METHODS 
All animal protocols and procedures were approved by the Kansas
 
University Medical 
Center’s Animal Care and Use Committee
 
and were in accordance with the National Institutes of 
Health
 
guidelines for the care and use of laboratory animals.
 
 
Immunohistochemistry 
Female Sprague Dawley rats were surgically ovariectomized (OVX) at 8 wks of age 
according to established methods (Zoubina et al., 2001). After 7 days, rats (n=4/group) received 
neck scruff subcutaneous implants of silastic tubing (inner/outer diameter = 1.575/3.175 mm, 
length = 20 mm, volume =170µl) containing sesame oil vehicle with or without 180µg/ml 17β 
estradiol (Sigma) (Strom et al., 2008), which raises serum estrogen levels in OVX rats from <15 
pg/ml to about 80 pg/ml (high physiological levels similar to estrus and term pregnancy). Seven 
days later, animals were euthanized by thoracotomy under isofluorene anesthesia, and vagina and 
dorsal root ganglia (DRG) harvested and fixed by overnight immersion in Zamboni’s fixative at 
4˚C and cryosectioned at 10 µm as described previously (Ting et al., 2004; Tague and Smith, 
2011). In groups used to analyze pSmad1 expression, rats received a single subcutaneous 
injection of 10µg/kg of 17β-estradiol which produces a rapid rise in serum estrogen (Zoubina et 
al., 2001) or sesame oil vehicle (n=3/group), and 24h later L6-S1 DRGs removed, fixed in 
neutral buffered formalin, and cryosectoned.    
Sections were immunostained overnight for peripherin (1:400, rabbit antiserum; 1:500, 
chicken antiserum, Millipore), Protein Gene Product 9.5 (PGP9.5, 1:1000, rabbit antiserum, 
Serotech), tyrosine hydroxylase (TH,1:200, rabbit antiserum, Millipore), calcitonin gene-related 
peptide (CGRP,1:400, sheep antiserum, Biomol), Enhanced Green Fluorescent Protein (EGFP, 
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1:750, chicken antiserum, Aves), BMP4 (1:100, mouse monoclonal antibody, Millipore), Bone 
Morphogenetic Protein Receptor type 1A (BMPR1A, 1:100, rabbit antiserum, Santa Cruz 
Biotech), Bone Morphogenetic Protein Receptor type 2 (BMPR2, 1:100, goat antiserum, Santa 
Cruz Biotech), α-smooth muscle actin (Cy3 conjugated mouse antiserum, Sigma), and 
Phosphorylated Smad1 (pSmad1, 1:200, rabbit monoclonal antibody, Cell Signaling 
Technologies).  Secondary antibodies included donkey anti-rabbit Cy3 at 1:200 (Jackson 
Immuno-Research), donkey anti-mouse Cy3 (1:200, Jackson Immuno-Research), donkey anti-
rabbit Alexa 488 (1:750, Invitrogen), donkey anti-rabbit Alexa 647 (1:500, Invitrogen), donkey 
anti-chicken Dylight 488 (1:750 Invitrogen), donkey anti-goat Cy3 (1:200 Jackson Immuno-
Research), and goat anti-rabbit Cy3 (1:200 Jackson Immuno-Research), donkey anti-sheep Cy3 
(1:200 Jackson Immuno-Research).  Antibodies have been previously characterized by our 
laboratory and others (Abir et al., 2008; Clarke et al., 2010; Tague et al., 2011; Tague and Smith, 
2011) and include omissions of primary and secondary antibodies and preabsorption of anti-
BMP4 with recombinant mouse BMP4 at 500ng/ml for 45min prior to staining. 
Retrograde Tracing 
Four days following OVX, rats were anesthetized by isoflurane inhalation.  Using a 
Hamilton syringe and 30 gauge needle, recombinant Cholera toxin-B (CTB) conjugated to Alexa 
488 (2µg/µl in PBS, Life Technologies) was injected submucosally at four sites equidistant along 
the vaginal circumference (2.5 µl/site; 10 µl total) at mid-vaginal level. Two days following CTB 
injection, rats received either a single subcutaneous injection of 10µg/kg 17β-estradiol (which 
produces a rapid rise in serum estrogen, (Zoubina et al., 2001) or sesame oil vehicle (n=5/group). 
Twenty-four h later, rats were deeply anesthetized with ketamine-xylazine and perfused 
transcardially with heparinized PBS followed by ice cold 4% formaldehyde in  
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PBS. L6, S1 and S2 DRGs, which are reported to give rise to vaginal innervation (Berkley et al., 
1993), were harvested and cryosectioned at 14 µ and immunostained for BMPR1A, BMPR2 and 
pSmad1, and co-stained for peripherin. Randomized images from 6-8 sections per animal were 
acquired and percentages of labeled neurons expressing specific markers assessed in 
approximately 200 retrogradely labeled neurons per rat. 
Flow cytometry 
L6 to S2 DRG were harvested aseptically from 8 week old female rats, diced  in ice-cold 
L15 medium with 3% glucose, incubated in 1mg/ml collagenase and 2.5 U/ml dispase 
(Worthington) in HBSS for 40mins, and triturated using fire-polished glass pipettes in L15-
glucose with 10%FBS. Cells were filtered through a 100μm mesh and centrifuged through a 
percoll gradient column to remove debris. The washed pellet was resuspended, fixed in cold 2% 
formaldehyde for 1h, and washed in PBST on ice. Cells were immunostained for 1h for 
peripherin (detected with donkey anti-chicken Alexa 488) and BMPR1A (donkey anti-rabbit 
Cy3) and fixed in 1% formaldehyde and washed. Fluorescence activated cell sorting was 
conducted using a BD Aria system, with cells categorized based on their fluorescence intensity 
in arbitrary units. 
PCR and immunoblots 
Effects of estrogen on BMP4 gene expression were assessed in vaginal tissue ex vivo.  
Vaginas from 8 week old OVX rats were cut along the length of the lumen, everted, and the 
mucosal surface gently scraped to remove the epithelium. Vaginal wall explants (1mm
3
) 
containing smooth muscle and adventitia were cultured in separate wells of a 24 well plate in 
DMEM/F12 medium for 24h with or without 20nM 17β estradiol, and homogenized in Trizol 
(Invitrogen) for RNA isolation. cDNA was synthesized from 1µg of total RNA using iScript 
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Reverse Transcriptase kit (Biorad). Semi-quantitative RT-PCR was performed for 30 cycles with 
55°C annealing temperature using primers for BMP4 (Forward: 
GAGCCTTTCCAGCAAGTTTGTTC; Reverse: GTTCTCCAGATGTTCTTCGTGATG; 
Product size: 487bp) and GAPDH (Forward: CTCTACCCACGGCAAGTT; Reverse: 
CTCAGCACCAGCATCACC; Product size: 120bp) and products separated on a 1% agarose gel 
for densitometric analysis.  
To assess BMP4 protein levels, western blots were performed from tissue collected from 
OVX rats with or without estrogen supplementation in vivo, as described above. Vaginal 
submucosa was homogenized in RIPA buffer, and 40µg total protein per well separated on a 
12% polyacrylamide gel, transfered to a PVDF membrane and probed with anti-BMP4 (mouse 
monoclonal antibody, Millipore,1:500) and reprobed for beta-actin (Sigma, 1:1000).  For 
evaluating BMP4 overexpression via lentiviral transduction, 24h conditioned medium was 
collected from stably infected 293T cells. From equal volumes of conditioned medium total 
protein was precipitated by TCA-acetone. Equal amounts of resuspended protein were used for 
immunoblot and probed for BMP4 as described above. 
Neuron and smooth muscle cultures 
L6 to S2 DRGs from 5-week-old were harvested as above. To assess neurite outgrowth in 
response to BMP4, neurons equivalent to one half of a DRG per well were plated onto collagen-
precoated 24 well plates (BD Biosciences) in serum-free Neurobasal  A medium (Gibco, Life 
Technologies) with B27 supplement (Gibco, Life Technologies) and 10 or 50 ng/ml mouse 
recombinant BMP4 (Peprotech) and cultured for 48h, with neurite quantification as described 
below.  For confocal imaging, some neuronal cultures were grown in defined medium for 48h on 
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laminin/poly D-lysine (Gibco, Life Technologies/Sigma-Aldrich) coated glass coverslips, fixed 
in 4% PFA, and immunostained for BMPR1A, BMPR2 and peripherin.  
For neuron-smooth muscle co-cultures, vaginal tissue from 8 week old rats was harvested 
in ice-cold L15 medium and stripped of epithelium with a sterile scalpel blade.  Portions of 
smooth muscle were dissected, diced, and immersed in L15 medium containing 2mg/ml 
collagenase (Sigma-Aldrich) on ice for 30min. Tissue was incubated at 37˚C for 30 min and then 
triturated using fire-polished glass pipettes while adding medium containing 10% FBS to 
neutralize the collagenase. The suspension was passed through 100μm mesh to remove debris, 
centrifuged at 300g for 7min, and the pellet resuspended in DMEM-10%FBS.  Cells were plated 
onto a collagen-coated 35mm dishes (BD Bioscience), incubated at 37
o
C in 5% CO2 for 48h, and 
then divided. To control for non-specific interactions between neurons and co-cultured cells, in 
some experiments we substituted rat embryonic fibroblasts cultured at greater than 7 passages for 
smooth muscle cells.  
L6 to S2 DRG from female rats aged 35 d were harvested aseptically and dissociated as 
described above. Neurons equivalent to one half ganglion per well were plated onto confluent 
layers of smooth muscle cells grown on collagen-coated 48-well plates (BD Biosciences).  Cells 
were co-cultured in the presence or absence of different amendments including 17-β estradiol 
(20nM), noggin (250ng/ml, Peprotech), anti-BMP4 (500ng/ml, Peprotech), and BMP4 (10ng/ml, 
Peprotech).  After 48h, co-cultures were fixed with 4% formaldehyde and washed with PBS. 
Cultures were immunostained for peripherin and in some cases for alpha smooth muscle actin. 
In some experiments, smooth muscle cells were prepared as above and initially grown in 
transwells (Corning) for 24h.   These were then transferred to 24-well plates in which dissociated 
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DRG neurons had been seeded on collagen. Transwell co-cultures were maintained for 48h in the 
presence or absence of anti-BMP4, fixed and immunostained as above. 
To quantify neurite outgrowth, 6-8 random images per well of peripherin expressing 
neurons were captured using a 20X objective (412 x 330 µm field size). Neurite
 
area was 
measured using a stereological grid (AnalySis
 
version 3.2; Soft Imaging System GmBH, 
Müenster, Germany)
 
superimposed over each image as described previously (Chakrabarty et al., 
2008).  Numbers of line intersections
 
overlying stained neurites were divided by total 
intersections
 
within the field and multiplied by total field area. Neurite area was
 
divided by the 
number of neurons with at least one neurite within
 
the field and all values in a well averaged and 
presented as neurite area per neuron.  
Lentivirus production and injections 
Full-length cDNA of rat BMP4 downstream to a CMV promoter was cloned into the 
FG12 lentiviral vector (Addgene) between XbaI and PacI restriction sites. The vector carries an 
EGFP reporter under a ubiquitin-C promoter. Third generation lentiviral packaging with 
pMDLg/RRE, pRSV-Rev, and pMD2.G (Addgene) was used to synthesize lentiviral particles for 
BMP4 and EGFP-only vectors.  293T cells were plated in 6 well plates at 60-80% confluence 
and transfected with the vector carrying the gene of interest or EGFP alone and all the 3 
packaging plasmids using Lipofectamine 2000 (Invitrogen) in Opti-MEM medium (Gibco). 
Medium was changed 12h later with OptiMEM-5%FBS and supernatant collected every 24h for 
2-3 days. Viral particles were concentrated from the supernatant by ultracentrifugation in sealed 
tubes for 2h at 35000 rpm and resuspended in sterile PBS. Lentiviral titers were measured using 
the Lentivirus qPCR titer kit (Applied Biological Materials).  
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OVX rats were anesthetized with ketamine/xylazine (70/6 mg per kg) and injected 
intravaginally using a 30 gauge needle attached by polyethylene tubing to a Hamilton syringe. 
Injections of lentivirus expressing BMP4 (n=4) or EGFP alone (n=4) were made at four 
intravaginal sites (corresponding to 3, 6, 9 and 12 o’clock), and a total volume of 10 µl 
containing 1x10
8
 viral particles was deposited into submucosal regions corresponding to the 
location of the vaginal smooth muscle. At the time of injection, rats were implanted with 
capsules containing sesame oil with or without 17β- estradiol (Ting et al., 2004; Strom et al., 
2008).  Seven days after injections and implantations, rats were euthanized and vaginal tissues 
harvested and fixed in Zamboni’s solution. Tissues were sectioned at 14 µm and immunostained 
for PGP 9.5, peripherin, CGRP, TH, BMP4 or EGFP. Innervation density was measured in 
images captured from regions corresponding to the injection sites as identified by BMP4 and 
EGFP expression, and from adjacent non-injected sites which did not show virally transduced 
gene expression. Eight to fourteen images were captured from injection and from adjacent sites 
for each animal, and axonal area within each 412 x 330 µm field was determined by thresholding 
(AnalySis Software) and averaged (Ting et al., 2004).  
Statistical analysis 
All values are presented as mean ± SEM. Comparisons between groups were made using 
Student’s t-test, one-way ANOVA, or two-way ANOVA with post-hoc comparisons by Student 
Newman-Kuels tests for normally distributed data, and Mann-Whitney rank sum test for non-
parametric analysis. Paired t-tests were used to compare innervation densities in injected and 
non-injected sites within the same animals in the lentiviral studies. Differences were considered 
significant at P≤0.05. 
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RESULTS 
BMP4 is expressed in adult rat vagina 
BMP 4 is an essential morphogen regulating vaginal development and is expressed in the 
early postnatal period (Cai, 2009). However, BMP4 expression has not been described in mature 
vagina. The vagina of the 8-week old rat consists of thickened mucosal epithelium surrounded by 
connective tissue containing a distinct smooth muscle layer (Fig. 1A).  Immunostaining showed 
abundant BMP4 labeling largely confined to the smooth muscle layer (Fig. 1B), which was 
eliminated by antibody preabsorption with recombinant BMP4 protein (Fig. 1C).  The smooth 
muscle layer also contains presumptive nociceptor innervation (Ting et al., 2004), and 
immunostaining revealed many axons immunoreactive for peripherin (Fig. 1B), an intermediate 
filament protein localized to axons and somata of small to medium diameter neurons, including 
dorsal root ganglion nociceptors (Ferri et al., 1990); (Goldstein et al., 1991) (Fornaro et al., 
2008).  
Estrogen downregulates BMP4 expression in vaginal smooth muscle 
Vaginal cells, including smooth muscle cells, express estrogen receptors that influence 
structure and function by altering gene expression (MacLean et al., 1990; Forsberg, 1995; Mowa 
and Iwanaga, 2000; Giraldi et al., 2002). To assess effects of estrogen on BMP4 expression in 
mature rat vaginal tissue, we performed RT-PCR on vaginal submucosal explants cultured for 
24h in presence or absence of 20nM estrogen. Semi-quantitative RT-PCR showed that, relative 
to GAPDH expression, estrogen downregulated BMP4 mRNA in the vaginal submucosal smooth 
muscle (Fig.1D). 
We evaluated changes in BMP4 protein content in 8 week old OVX rats implanted with 
17β estradiol-releasing capsules for 7 days.  In western blot analysis, vaginal BMP4 protein 
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levels normalized to β-actin were reduced in animals receiving estrogen as compared to vehicle 
controls (Fig.1E), indicating that estrogen reduces both BMP4 mRNA and protein. 
Adult DRG neurons express BMP receptors 
BMP4 acts by binding to cell surface receptors that are typically heterodimers consisting 
of BMPR2 and BMPR1A or BMPR1B.  Cervical and thoracic DRG sensory neurons express 
BMPR2 and predominantly BMPR1A (but not BMPR1B) during development (Zhang et al., 
1998), but their presence in more caudal ganglia and persistence into adulthood are unclear. To 
assess BMP receptor presence and distribution, we performed Fluorescence Activated Cell 
Sorting (FACS) of 8-week old rat dissociated DRGs from L6-S2, which innervate the rat vagina 
(Berkley et al., 1993).  FACS revealed a substantial cell population with intense fluorescence for 
both peripherin and BMPR1A (Fig. 2A, P6), confirming the presence of this receptor in the 
peripherin-immunoreactive population of neurons.  A second population of peripherin positive 
neurons showed lower levels of BMPR1A expression (P4). Additional cells showed low 
peripherin and low to high BMPR1A-ir (P8, P7). 
We examined DRG sections to further assess BMP4 receptor localization.  BMPR1A-ir 
was observed primarily in peripherin expressing neurons, with smaller numbers of peripherin-
positive neurons lacking BMPR1A-ir and a few peripherin negative, large diameter neurons 
expressing the receptor (Fig. 2B-D); preliminary studies confirmed a paucity of BMPR1B 
staining (not shown).  Immunostaining for BMPR2 showed that this co-receptor was also 
enriched in peripherin immunoreactive neurons (Fig. 2E-G).  BMPR2-ir was observed 
additionally in large diameter neurons, although the signal intensity was typically less than that 
of peripherin positive neurons. 
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We assessed the distribution of BMP4 receptors within peripherin-positive neurons in 
culture (Fig. 2H, I).  Both BMPR1A and BMPR2 showed strong immunostaining throughout the 
soma and axons (Fig. 2J, K). 
To confirm that small-diameter neurons projecting to the vagina express BMPR1A and 
BMPR2 receptors, we immunostained sections of DRGs 3d following CTB injection of the 
vaginal submucosa in OVX rats with or without estrogen supplementation.  CTB-labeled 
neurons were present bilaterally in L6-S2 DRGs (Fig. 3A, B). Analysis of peripherin-
immunostained sections revealed that 61±3% of CTB-labeled neurons were immunoreactive for 
this small-diameter neuron marker (Fig. 3C, D).  BMPR1A-ir was associated with many CTB-
labeled cells (Fig. 3E); quantitative analysis revealed that more than two thirds of vagina-
projecting neurons expressed BMPR1A (70+4% in OVX, 67+4% after estrogen); most of these 
were also peripherin positive (Fig. 3G; 63+3% in OVX, 54+12% after estrogen).   BMPR2-ir 
also was observed in a majority CTB-labeled neurons (Fig. 3F; 81+3% in OVX, 71+7% after 
estrogen), with most of these immunoreactive for peripherin (Fig. 3H; 64+4% in OVX, 64+4% 
after estrogen).  Estrogen status did not influence BMPR expression. 
BMP4 mediates smooth muscle-induced sensory neurite outgrowth  
Our findings show that DRG sensory neurons, including those projecting to the vagina, 
express BMP4 receptors, and that vaginal target cells synthesize BMP4 more robustly in low-
estrogen conditions.  Accordingly, reduced BMP4 protein levels could contribute to vaginal axon 
pruning that occurs when estrogen levels are elevated, as in term pregnancy (Liao and Smith, 
2011) and following exogenous hormone replacement (Ting et al., 2004; Griebling et al., 2011). 
We tested the responsiveness to BMP4 of primary sensory neurons plated on collagen in 
defined media. The addition of10ng/ml recombinant BMP4 increased axon outgrowth relative to 
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that in control media (Fig. 4A); outgrowth was not increased further at 50ng/ml. To delineate 
whether BMP4 plays a functional role in target regulation of sensory innervation, we cultured 
dissociated DRG neurons atop near-confluent vaginal smooth muscle cells. Individual neurons 
elaborated neurite arbors that made multiple contacts with smooth muscle cells (Fig. 4B).  We 
first determined whether members of the BMP family contribute to smooth muscle-induced 
sprouting by treating cultures with noggin, an endogenous inhibitor of BMP4 (McMahon et al., 
1998; Sela-Donenfeld and Kalcheim, 1999b).  Noggin at concentrations of 250ng/ml appeared to 
decrease neurite outgrowth relative to control cultures at 48 hrs (Fig. 4C, D), and this was 
confirmed by quantifying neurite area per viable neuron, where noggin reduced outgrowth by 
38% (Fig. 4E).  When adult DRG neurons were cultured under the same conditions but in the 
absence of smooth muscle cells, noggin failed to alter neurite outgrowth (data not shown).  These 
findings implicate BMPs in smooth muscle cell mediated sensory neuronal sprouting. 
While noggin is an effective endogenous inhibitor of BMP4, it can bind other members 
of the BMP family of proteins. To ensure that reduced neurite outgrowth observed with noggin is 
due to BMP4 neutralization, we used a function neutralizing antibody directed specifically 
against BMP4.  Relative to control cultures (Fig. 4F), BMP4 antibody reduced neurite outgrowth 
by 32% (Fig.4G, H) but did not affect outgrowth by neurons cultured in the absence of smooth 
muscle (data not shown).  
To confirm that the effects of the BMP4 function neutralizing antibody are dependent 
upon BMP4 synthesis by co-cultured cells, we grew DRG neurons with rat embryonic fibroblasts 
which are not believed to synthesize BMP4.  The addition of anti-BMP4 to the culture medium 
did not alter neurite outgrowth (6381±482µm
2
 control vs. 6210±675µm
2
 anti-BMP4).  
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BMP4 is a secreted protein that influences its targets by way of diffusion.  To ensure that 
BMP4 is acting as a secreted factor and not through any direct physical interaction between 
neuron and muscle, smooth muscle cells were cultured in transwell inserts that allow diffusible 
factors to reach neurons growing at the bottom of the culture well but prevent direct interactions.  
The addition of BMP4 neutralizing antibody to the culture medium was as effective in inhibiting 
outgrowth in these transwell co-cultures as it was when neurons and smooth muscle were in 
direct contact (Fig. 4H).  
Estrogen modulates smooth muscle-mediated axon growth in vitro via BMP4 
Protein and RNA measurements show that estrogen reduces vaginal BMP4 expression. 
To assess whether estrogen modulates smooth muscle-induced outgrowth by way of BMP4, we 
grew vaginal smooth muscle cells in culture for 72 h in the presence or absence of 17β estradiol.  
Adult DRG neurons were then plated over the near-confluent cultures in estrogen-free medium.  
Measurement of axon length per neuron showed that outgrowth at 48 h was significantly lower 
in the estrogen-pretreated muscle cell cultures as compared to the untreated cultures (Fig. 5A, B, 
D). 
We reasoned that if reduced outgrowth in estrogen-pretreated cultures is due to the 
reduction in BMP4 protein, then we should be able to reverse it by adding exogenous BMP4 to 
the estrogen pretreated cultures. We performed smooth muscle-DRG neuronal co-cultures as 
above and added recombinant BMP4 to the medium in one estrogen pretreated group at the time 
of neuronal plating.  Forty-eight h after adding BMP4 to cultures pretreated with estrogen, 
outgrowth was increased significantly relative to cultures pretreated with estrogen alone, and was 
statistically comparable to that seen in co-cultures where smooth muscle cells were not treated 
with estrogen (Fig. 5C, D).  
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Estrogen-modulated axon plasticity is associated with changes in DRG pSmad1 
BMP4 binds to cell surface receptors that induce phosphorylation of cytoplasmic Smad1.  
pSmad1 travels to nucleus to regulate transcription factors mediating axonal outgrowth (Zou et 
al., 2009).  If estrogen regulates axonal outgrowth by way of BMP4 signaling, then nuclear 
pSmad1 localization should be reduced when vaginal sensory innervation is lower. We 
investigated pSmad1 expression in L6-S2 DRGs which originate vaginal innervation.  Under 
low-estrogen conditions in OVX rats, many pSmad1 positive nuclei were evident (Fig. 6A). 24h 
after estrogen injection, pSmad1 immunoreactive nuclei were much less frequent (Fig. 6B), with 
quantitative analysis showing an 85% reduction of pSmad1 labeled nuclei (Fig. 6C).  Double 
immunostaining showed that many pSmad1 positive nuclei were present in peripherin expressing 
neurons (Fig. 6D).  
To confirm that global changes in pSmad1 expression also occur in vagina-projecting 
neurons, we assessed pSmad1-ir in retrogradely labeled L6-S2 DRG neurons (Fig. 6E, G). In 
OVX rats, nearly all CTB-labeled peripherin positive neurons displayed pSmad1-ir (Fig. 6F); 
about half of the peripherin-negative CTB-labeled neurons also contained pSmad1-ir.  Following 
estrogen administration, numbers of pSmad1, CTB-labeled, peripherin-positive neurons (Fig. 
6H) were reduced by approximately 60% (Fig. 6I); non-peripherin-ir CTB labeled neurons 
showed a smaller reduction of about 20% (Fig. 6I).    
Local viral expression of BMP4 prevents estrogen-induced nerve depletion in vivo 
These findings are consistent with the hypothesis that vaginal innervation density is 
regulated in part by estrogen’s suppression of BMP4 synthesis. If so, then sustained BMP4 
synthesis despite estrogen elevation should prevent this reduction in innervation.  We used a 
lentiviral delivery system to drive BMP4 gene expression by the estrogen-independent CMV 
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promoter.  The vector also expresses EGFP reporter under the UbiC promoter.  Competence of 
the lentiviral agent was confirmed by assessing BMP4 gene and protein expression in transduced 
293T cells (Fig. 7A, B).  
OVX rats received vaginal submucosal lentiviral injections and were concurrently 
implanted with vehicle- or estrogen-releasing capsules and maintained for 7d.  To identify 
regions that had incorporated viral gene expression, tissue was visualized using fluorescent 
stereomicroscopy and the vagina was cut transversely through the region showing the greatest 
EGFP fluorescence (Fig. 7C).  Cryosections through this region showed EGFP expression in 
individual cells within the vaginal smooth muscle layer (Fig. 7D). In OVX rats injected with the 
BMP4 vector and receiving estrogen, smooth muscle showed elevated BMP4-ir (Fig. 7E) relative 
to rats receiving the EGFP vector alone (Fig. 7F) and as compared to regions adjacent to the 
injection sites.  
We next determined whether sustained BMP4 expression prevents the reduction in 
vaginal innervation that occurs normally with estrogen elevation.  OVX rats show reduced 
vaginal PGP9.5 immunoreactive innervation after 7 d of estrogen supplementation (Ting et al., 
2004).  Assessment of tissues adjacent to sites injected with lentivirus carrying BMP4 or EGFP 
constructs was similar to that described previously.   Injection of lentivirus containing the EGFP 
vector alone also did not affect innervation as assessed using PGP9.5-ir (Fig. 8A, C) or 
peripherin (Fig. 8D).  Sites injected with lentivirus carrying the BMP4 construct exhibited 
innervation patterns similar to controls but did not show the reduced innervation density 
normally seen after estrogen administration (Fig. 8B, C, D).  
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We investigated whether the effects of BMP4 are selective for different populations of 
vaginal axons. Putative peptidergic nociceptors were identified by immunostaining for CGRP 
(Lawson, 1992).  Axon density was similar in uninjected and EGFP-vector-injected tissues but 
was increased in tissues receiving BMP4 lentivirus (Fig. 9A, B, C).  In contrast, using TH-ir as a 
marker for sympathetic axons, we found no differences in innervation density among any of the 
sampled regions (Fig. 9D). 
DISCUSSION 
 BMP4 regulates development of many smooth muscle targets by promoting 
differentiation, organization, and maturation of smooth muscle cells.  Typically, BMP4 from 
adjacent epithelium, endothelium or fibroblasts acts in a paracrine fashion to regulate smooth 
muscle development (Frank et al., 2005; Cai, 2009; Wang et al., 2009; Tasian et al., 2010).  Our 
findings show that in the adult, vaginal smooth muscle cells themselves synthesize BMP4, 
raising the possibility that BMP4 may also act in an autocrine fashion. Indeed, a recent report 
suggests that BMP4 exerts an autocrine effect to promote myotube formation by C2C12 cells 
(Umemoto et al., 2011).  Hence, BMP4 may have roles in regulating smooth muscle integrity 
and function beyond the developmental period. 
Smooth muscle cells are generally well innervated by peripheral axons and, accordingly, 
secrete a number of proteins that potentially influence axon growth and integrity.  These include 
neurotrophins, extracellular matrix components, growth factors and cytokines (Weintraub et al., 
1996; Knox et al., 2001; Gerthoffer and Singer, 2002; Krizsan-Agbas et al., 2003; Krizsan-Agbas 
et al., 2008). However, members of the BMP family of proteins have not been identified 
previously as regulators of peripheral innervation in the adult.  In early development, BMP4 is 
critical for peripheral neuron migration and maturation, including formation of trigeminal 
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sensory facial maps and phenotype specification of DRG neurons (Hall et al., 2002; Guha et al., 
2004; Hodge et al., 2007). The present study shows that BMP4 mediates peripheral sensory axon 
plasticity in the adult as well. DRG neurons express BMP4 receptors, and both smooth muscle-
derived and exogenous BMP4 exert similar effects in stimulating sensory (but not sympathetic) 
axon outgrowth. While BMP4 is likely to induce outgrowth by interacting with axonal receptors 
proximate to sites of target synthesis, we did not directly demonstrate BMP4 receptors on 
terminals and therefore cannot rule out effects on other regions of the axon or soma which 
uniformly express these receptors. It is noteworthy that other members of the TGFβ family of 
proteins are known to interact with growth factors such as NGF to influence sensory neuron 
phenotype (Ai et al., 1999; Hall et al., 2002); hence the ultimate effects of BMP4 in vivo will 
clearly be determined by combinatorial influences that occur in conjunction with other local 
regulatory molecules.  Nonetheless, our findings that DRG axon outgrowth is enhanced when 
BMP4 levels are increased in defined culture conditions, as well as when they are selectively 
increased by viral transduction in vivo, lend strong support to the idea that BMP4 acts directly as 
a pro-neuritogenic factor for at least some types of peripheral neurons in the mature organism.  
In developing tissues, many factors regulate BMP4 expression including FGF3, vitamin 
A, and the wnt and notch signaling pathways (Baker et al., 1999; Endo et al., 2003; Baleato et 
al., 2005).  Much less is known about the regulation of BMP4 synthesis in mature tissues.  Our 
findings show that estrogen is an important factor in determining BMP4 expression in adult 
smooth muscle.  Hence, both BMP4 mRNA and protein levels are decreased when vaginal tissue 
is cultured in the presence of estrogen.  Because these studies were conducted ex vivo, we can 
exclude the possibility that estrogen acts indirectly by altering other hormonal systems.  
Similarly, since vaginal smooth muscle cells possess estrogen receptors, this is most likely a 
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direct effect on the smooth muscle (although we cannot exclude paracrine effects by other 
estrogen-responsive cells present in the explanted tissue). Consistent with a direct effect of 
estrogen, in silico analysis reveals several putative EREs upstream of the BMP4 gene (data not 
shown).  As illustrated by our findings at 24h ex vivo and 7 day in vivo, estrogen has both short-
term and sustained regulatory effects on BMP4 expression. In support of the idea that estrogen is 
a negative regulator of BMP4 expression, a recent report shows that BMP4 levels are elevated in 
prostate gland stromal cells of the estrogen receptor alpha knockout mouse (Chen et al., 2009).  
It therefore appears that estrogen can act to suppress BMP4 synthesis in multiple mature tissues 
types. 
 A striking feature of the female reproductive tract is the extensive and relatively rapid 
degree to which innervation remodeling occurs in conjunction with varying reproductive states.  
Our findings are consistent with the hypothesis that BMP4 plays a major role in this remodeling.  
Dispersed DRG neuron-vaginal smooth muscle co-cultures showed that estrogen’s ability to 
diminish axon sprouting is fully reversed by addition of exogenous BMP4, supporting the idea 
that this cytokine is responsible for promoting outgrowth under low-estrogen conditions. This 
was illustrated most vividly in in vivo lentiviral transduction studies where smooth muscle cells 
containing the estrogen-independent CMV-promoter-driven BMP4 transcript showed high levels 
of sensory innervation whereas regions immediately adjacent that had only native, estrogen-
dependent BMP4 expression showed markedly reduced innervation.  Therefore, diminished 
BMP4 expression accounts, at least in part, for reduced vaginal innervation density when 
estrogen levels rise.   
Several lines of evidence show that BMP-Smad signaling plays a crucial role in nerve 
regeneration following injury. Analysis of the transcriptome of DRG neurons following distal 
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axon injury showed that Smad1 is strongly upregulated during regeneration, and that this 
transcription factor is obligatory, as siRNA knockdown abrogated regenerative outgrowth (Zou 
et al., 2009).  The importance of BMP induction of Smad1 in axon regeneration has recently 
been shown in studies of DRG neurons following spinal cord injury.  Central DRG axons, which 
normally show minimal regenerative capacity, displayed more robust outgrowth through the 
lesion when BMP4 was overexpressed in neurons through viral transduction (Parikh et al., 2011).  
In contrast, blocking BMP signaling by administering noggin or ablating the BMP co-receptor, 
RMGb, inhibited DRG neuronal outgrowth following axotomy (Ma et al., 2011). Therefore, 
BMPs acting through the Smad1 pathway are among a number of different cytokines (Dubovy, 
2011) that are implicated in the initiation of axon regeneration following injury.  
We show here that BMP4/Smad1 signaling is also critical in determining target 
innervation under physiological conditions.  In lumbar DRGs giving rise to vaginal innervation, 
low estrogen levels following ovariectomy were accompanied by high vaginal innervation 
density (presumably a result of axon sprouting), and levels of nuclear pSmad1 were high in 
peripherin expressing neurons including those that project to the vagina.  While possible 
contributions of non-canonical signaling mechanisms (Sanchez-Camacho and Bovolenta, 2009) 
cannot be ruled out, these findings support the hypothesis that smooth muscle-derived BMP4 
acts on DRG peripherin-positive neurons to induce Smad1 phosphorylation and nuclear 
translocation as a prelude to terminal sensory axon outgrowth in the estrogen-deprived vagina. 
Alterations in estrogen status are associated with changes in vaginal autonomic as well as 
sensory innervation in both rats and humans (Ting et al., 2004; Griebling et al., 2011).  While 
lentiviral BMP4 overexpression mimicked the effect of ovariectomy on CGRP immunoreactive 
sensory axons, TH expressing sympathetic axons were unaffected. This implies that, although 
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both sensory and autonomic neuronal progenitors are responsive to BMP4 in early development 
(Guha et al., 2004; Liu et al., 2005), BMP4 influences only sensory innervation density in the 
mature organism.  It is unclear why mature sympathetic neurons are not responsive, but it seems 
likely that other estrogen-regulated factors are involved in achieving the full repertoire of vaginal 
axon remodeling.  Estrogen is known to influence the expression of trophic proteins (Bjorling et 
al., 2002), as well as factors shown to be repulsive to sympathetic axons (Krizsan-Agbas et al., 
2003; Krizsan-Agbas et al., 2008; Richeri et al., 2011).  Hence, while our findings show that 
BMP4 signaling is necessary and sufficient to achieve high levels of sensory CGRP innervation, 
it is clear that estrogen-mediated regulation of reproductive tract innervation involves complex 
interactions at the level of the target and neuron. 
Abnormal sensory innervation is a hallmark feature of some female pain syndromes.  
Vulvodynia, characterized by abnormal sensitivity of the genital tissues, affects some 16% of the 
adult female population (Harlow and Stewart, 2003), and the ‘provoked’ form of this disorder is 
associated with marked hyperinnervation of the vaginal vestibule by CGRP immunoreactive 
axons (Bohm-Starke et al., 1999; Tympanidis et al., 2003) and impaired estrogen receptor 
signaling (Eva et al., 2003); excising the hyperinnervated  region frequently alleviates the pain 
(Goetsch, 1996).  ‘Spontaneous’ vulvodynia selectively affects perimenopausal women, where 
estrogen levels are low and vaginal hyperinnervation also occurs (Griebling et al., 2011).  
Although the present study does not directly demonstrate that BMP4 elevation leads to 
hypersensitivity, several lines of evidence support this concept: i) Smad signaling pathways 
activated by BMP4 and related ligands are implicated in regulating DRG neuron excitability and 
pain sensitivity (Jeub et al., 2011);  ii) our findings show that BMP4 selectively promotes 
sprouting of axons with a peripherin/CGRP-positive phenotype corresponding to small diameter 
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nociceptors (Bove and Light, 1995; Goldstein et al., 1996), and axons with this phenotype appear 
to be obligatory for detecting some types of noxious stimuli (McCoy et al., 2012);  iii) the 
proliferation of these axons in OVX comports well with the previously documented 
hypersensitivity to vaginal distension that occurs under this low-estrogen condition (Bradshaw 
and Berkley, 2002; Ting et al., 2004); and iv) proliferation of peripheral axons of comparable 
phenotype is now documented as a common feature of many painful conditions (Di Sebastiano et 
al., 1995; Brown et al., 1997; Schubert et al., 2005; Tague et al., 2011). While additional 
research is required to fully define the interrelationships among innervation, estrogen and pain 
sensitivity, BMP4 clearly represents a potent estrogen-regulated determinant of peripheral 
sensory innervation. 
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Figure 1.  BMP4 expression and regulation in the adult rat vagina.  A. Low magnification image 
shows gross histology of the vagina in cross section. Alpha-smooth muscle actin-
immunoreactivity (ir) reveals the submucosal smooth muscle layer (red), which lies beneath the 
epithelium demarcated by the dense aggregation of DAPI-stained nuclei (blue). B. BMP4-ir (red) 
is expressed almost exclusively within smooth muscle (SM) lying beneath the epithelium (E) and 
this corresponds to the location of most peripherin positive axons (green). C. Preabsorption of 
the BMP4 antibody with an excess of mouse recombinant BMP4 eliminated staining of vaginal 
tissues. Bars=50µm. D. Submucosal vaginal tissue explants cultured for 24h with 20 nM 
estrogen (E2) show reduced BMP4 gene expression by RT-PCR relative to GAPDH as compared 
to untreated controls (C).  E. In vivo treatment of ovariectomized rats for 7 d with estrogen also 
reduced BMP4 protein levels relative to β-actin as assessed by immunoblot.  
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Figure 2. 
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Figure 2.  BMP receptors are expressed in L6 to S2 sensory neurons. A.  Fluorescence activated 
cell sorting of dissociated DRG cells immunolabeled for BMPR1A (Cy3) and peripherin (Alexa 
488) reveal high levels of BMPR1A fluorescence intensity in cells displaying high peripherin 
fluorescence intensity (P6). Other populations include peripherin-negative cells with high 
BMPR1A (P7), peripherin-positive cells with low BMPR1A expression (P4), and cells negative 
for either marker (P8).  B.  Immunostaining of an L6 DRG section shows BMPR1A protein is 
widely distributed; inset is a higher power image showing BMPR1A localized predominantly 
within neurons. C. Distribution of peripherin immunostaining in the section shown in B.  D.  A 
merged image shows that BMPR1A-ir is present predominantly in peripherin-positive neurons.  
E.  BMPR2 immunostaining shows wider localization across different neuronal subtypes.  F.  
Immunostaining reveals peripherin expressing DRG neurons in E.  G. Most peripherin-positive 
neurons show BMPR2 immunoreactivity.  H, I.  Peripherin immunoreactive neurons in 
dissociated DRG culture. Immunostaining for BMPR1A (J) and BMPR2 (K) show that both 
receptors are present throughout the axons (arrows) as well as the cell body.  Scale bar in all 
panels and insets = 50 μm.  
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Figure 3. 
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Figure 3. Vagina-projecting neurons express BMP4 receptors.  A, B.  Neurons projecting 
specifically to the vaginal submucosa were labeled following Alexa-488 conjugated recombinant 
Cholera Toxin-B injection (CTB), as shown here in an S1 dorsal root ganglion.  C, D. 
Retrogradely labeled neurons frequently display peripherin immunoreactivity.  E, F.  Vagina-
projecting neurons exhibit immunoreactivity for both BMPR1A and BMPR2.  G, H. Arrows 
indicate CTB-labeled, peripherin positive neurons expressing BMPR. Arrowheads indicate CTB-
labeled, peripherin negative neurons expressing BMPR. Scale bar in H = 50µm in all panels. 
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Figure 4. 
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Figure 4.  Target-derived BMP4 promotes sensory neurite outgrowth. A. Dissociated dorsal root 
ganglion neurons grown on collagen coated plates showed increased neurite outgrowth in the 
presence of 10ng/ml or 50ng/ml BMP4 (*P<0.007).  B. Vaginal smooth muscle cells 
immunostained for α-smooth muscle actin (red) were grown on collagen-coated plastic. Dorsal 
root ganglion neurons immunostained for peripherin (green) were plated on smooth muscle cells, 
and most extended neurites that made contacts with muscle cells at 48h. C. Vehicle treated co-
cultures immunostained for peripherin showed many neurites.  D. Co-cultures treated with 
noggin (250ng/ml) had fewer neurites. E. Quantitative analysis confirmed a reduction in neurite 
outgrowth per neuron in noggin treated co-cultures (**P=0.001).  F.  Neurites elaborated by 
neurons grown directly on smooth muscle co-cultures (Control) are reduced by the addition of a 
BMP4 function-neutralizing antibody (#P=0.005 G, H).  Anti-BMP4 was equally effective in 
reducing axon outgrowth when smooth muscle cells were grown in transwell inserts (H, Control-
T, Anti-BMP4-T, ##P=0.004).  Bars in C and F = 50 µm. 
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Figure 5. 
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Figure 5.  Neurite outgrowth in co-cultures is downregulated by estrogen and rescued by 
exogenous BMP4. A.  Smooth muscle cells (unstained) were grown for 72 hours, on which 
dissociated sensory neurons (green) were cultured for 48h (bar = 50 µm in A-C). B.  When 
smooth muscle cells were grown in the presence of 2x10
-8 
M 17β estradiol, neurite outgrowth 
appeared to be reduced. C.  Addition of 10 ng/ml recombinant BMP4 appeared to increase 
numbers of neurites. D. Quantitative analysis showed that neurite outgrowth per neuron was 
reduced by estrogen (E2) pretreatment (*P= 0.001 vs. Control), and the decrease was abrogated 
by BMP4 (#P=0.004 vs. E2). There was no significant difference between Control and 
E2+BMP4. 
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Figure 6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
 
 
 
Figure 6.  pSmad1 expression in dorsal root ganglion neurons is reduced after estrogen 
administration.  A. In vehicle-injected ovariectomized (OVX) rats, many nuclei show high levels 
of pSmad1-ir (arrows). B. 24h following estrogen administration (OVX+E2), pSmad1-positive 
nuclei were observed infrequently. C. Quantitative analysis confirms that numbers of pSmad1-
positive nuclei are markedly reduced by estrogen administration (#P=0.038).   D. Double-
immunostaining for peripherin (green) and pSmad1 (red) show that positive nuclei are frequently 
present in peripherin positive neurons in the OVX rat. E. Vaginal submucosal injection of CTB 
resulted in retrograde labeling of DRG neurons of OVX rats.  F. Several CTB labeled neurons in 
this low-estrogen condition (E) display nuclear pSmad1. Arrows points to peripherin positive 
CTB labeled neurons and arrowhead shows a peripherin negative CTB neuron. G.  Vaginal CTB 
injection also labeled DRG neurons in OVX rats receiving estrogen.  H. In presence of estrogen, 
CTB labeled neurons (G) in both peripherin positive (arrow) and negative (arrowhead) groups 
were frequently pSmad1 negative. I. In CTB-labeled neurons, pSmad1immunoreactive nuclei 
occurred more frequently in peripherin positive as compared to peripherin negative neurons 
(P=0.004 by 2-way anova).  Both populations responded to estrogen with a reduction in the 
percentage of pSmad1 expressing nuclei (*P<0.001, **P=0.034 by Student Newman-Kuels 
tests).  However, the decline was much stronger in the peripherin positive population (P=0.007). 
All images from the L6 and S1 DRG.  Scale bars = 50 μm. 
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Figure 7. 
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Figure 7. Lentiviral injection regulates BMP4 expression in vaginal smooth muscle.  A. 293T 
cells overexpress BMP4 as assessed by RT-PCR 48 h after transduction with viral particles 
containing vectors for EGFP-BMP4 expression compared to those with only EGFP expressing 
control. GAPDH was used as a housekeeping control gene. B. Immunoblot showing abundant 
amounts of secreted BMP4 protein in conditioned media of 293T cells transduced with EGFP-
BMP4 compared to EGFP alone. C. Bright field and epifluorescence overlay of the whole vagina 
(cut transversely) shows intense EFGP fluorescence at the injection site (arrowhead) at 7d. 
Arrow indicates the vaginal orifice. D. Overlay of DAPI staining and EGFP in a section of the 
specimen shown in C. Arrow indicates abundant EGFP expression in the smooth muscle layer 
(Scale bar = 200µm).  E. Immunostaining for BMP4 shows robust fluorescence in vaginal 
smooth muscle (arrow) of an estrogen-treated OVX rat transduced with EGFP-BMP4 at 7d.  F. 
Estrogen-treated rats receiving control virus with EGFP alone showed very low levels of BMP4 
immunostaining.  Scale bars in E and F = 50µm. 
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Figure 8. 
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Figure 8. BMP4 overexpression preserves vaginal innervation at high estrogen. A.  
Immunostaining for PGP9.5 at the site of injection 7d following injection of lentivirus driving 
expression of only EGFP (EGFP-Inj) showed low innervation density typical of OVX rats 
receiving estrogen supplementation.  B. PGP positive innervation density at sites injected with 
lentivirus driving BMP4 expression (BMP4-Inj) was considerably higher, characteristic of low-
estrogen OVX rats (scale bar = 50µm). C.  Injection of EGFP lentivirus did not alter innervation 
density relative to uninjected adjacent tissues (EGFP Adj), or to innervation at sites adjacent to 
injection with the BMP4 lentivirus (BMP4 Adj).  Innervation density at sites receiving BMP4 
lentivirus was significantly greater than that of other sites (*P=0.019 for BMP4 Inj vs. EGFP Inj, 
and **P=0.026 for BMP4 Inj vs. BMP4 Adj). D. Staining for peripherin confirmed that changes 
noted with PGP9.5 also occur within this axonal population (#P≤0.001 for BMP4 Inj vs. EGFP 
Inj, and ##P≤0.001 for BMP4 Inj vs. BMP4 Adj).  
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Figure 9. 
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Fig. 9. BMP4 over-expression selectively affects sensory innervation density. A. In OVX rats 
receiving estrogen and injected with EGFP lentivirus (EGFP Inj) sensory axons immunoreactive 
for calcitonin gene-related peptide (CGRP) were depleted.  B.  Sites injected with the BMP4 
lentivirus (BMP4 Inj) showed higher levels of CGRP immunoreactive innervation. Scale Bar = 
50µm.  C.  Quantitative analysis confirmed that CGRP axon density in tissue receiving BMP4 
lentiviral injections was greater than that of tissue adjacent to the injection site (BMP Adj, 
*P=0.012) and to tissue receiving EGFP lentivirus (EGFP Inj, **P=0.049). D.  In contrast, 
injection with BMP4 lentivirus did not affect densities of axons expressing the sympathetic axon 
marker tyrosine hydroxylase (TH).  
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Chapter 3. Trophic factor and hormonal regulation of neurite outgrowth in sensory 
neuron-like 50B11cells 
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ABSTRACT 
Sensory axon integrity and regenerative capacity are important considerations in 
understanding neuropathological conditions characterized by hyper- or insensitivity.  However, 
our knowledge of mechanisms regulating axon outgrowth are limited by an absence of suitable 
high-throughput assay systems employing cells that are easily grown and faithfully display 
phenotypes similar to primary nociceptive neurons. While several model cell lines for dorsal root 
ganglion neurons have been proposed, most have not accurately captured the sensory neuronal 
phenotype, particularly with regard to their ability to rapidly extend axons in culture. The 50B11 
cell line generated from rat embryonic dorsal root ganglion neurons offers a promising model for 
screening assays. These cells have been partially characterized and shown to express cytoskeletal 
proteins and genes encoding ion channels and neurotrophin receptors in common with sensory 
nociceptor neurons. In the present study we further characterized 50B11 cell phenotypes and 
quantified axon outgrowth induced by neurotrophic and hormonal factors. 
50B11 cells express cytoplasmic proteins characteristic of small, unmyelinated sensory 
neurons including the microtubular protein beta-3 tubulin, the intermediate filament protein 
peripherin (a marker of unmyelinated neurons), and the pan-neuronal ubiquitin hydrolase, 
PGP9.5.  In these short-term cultures only PGP9.5 immunoreactivity was uniformly distributed 
throughout soma and axons, and therefore presented the best means for visualizing the entire 
axon arbor.  All cells co-express both NGF and GDNF receptors and addition of these ligands 
increased neurite length. 50B11 cells also showed immunoreactivity for the estrogen receptor-α 
and the angiotensin receptor type II, and both 17-β estradiol and angiotensin II increased 
outgrowth by differentiated cells. 
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50B11 cells show many features in common with primary unmyelinated nociceptor 
neurons.  They are responsive to the axonal growth-promoting actions of classical neurotrophic 
factors as well as hormonal modulators.  Coupled with their ease of culture and predictable 
differentiation, 50B11 cells represent a promising cell line on which to base assays that more 
clearly reveal mechanisms regulating axon outgrowth and integrity which may give rise to new 
therapeutic targets.  
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INTRODUCTION 
The raison d’etre of the nervous system is to acquire, transmit and process information.  
Peripheral sensory innervation is critical in transducing environmental information necessary for 
awareness and protection of the organism. Pathological loss of peripheral axons of sensory dorsal 
root ganglion (DRG) neurons underlies common forms of neuropathy affecting many clinical 
populations including diabetics and cancer survivors who received chemotherapy (Younger, 
2004; Jaggi and Singh, 2012). Similarly, abnormal proliferation of DRG sensory axons occurs in 
many chronic inflammatory pain syndromes (Chakrabarty et al., 2011; Tague et al., 2011).  Thus, 
appropriate structural geometry of peripheral axons appears to be critical for ensuring optimal 
sensory function.  
Factors regulating DRG target innervation are incompletely understood.  A reason for our 
limited understanding is a lack of robust assay systems. Primary DRG cultures have long 
provided the main means for assessing factors regulating axon outgrowth in vitro.  However, 
primary cultures are limited by low throughput, cellular heterogeneity, and tedious preparation 
protocols.  Attempts to simulate sensory outgrowth in vitro have included PC12 cells and 
neuroblastomas (Radio et al., 2008; Radio and Mundy, 2008), but with limited success.  
Immortalized cell lines generated from rat, mouse and human DRGs have included the F11 cell 
line which fused mouse hybridoma with rat embryonic DRG neurons (Platika et al., 1985a; 
Platika et al., 1985b), the ND lines generated by fusing neonatal mouse DRG cells with 
neuroblastoma cells (Wood et al., 1990) and the HD10.6 lines derived by incorporating a 
tetracycline-inducible v-myc oncogene into 3
rd
 trimester human embryonic DRG neurons 
(Raymon et al., 1999). While these lines have been useful in analyzing sensory neuron 
electrophysiology, signaling and biochemistry (Wood et al., 1990; Fan et al., 1992; Faravelli et 
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al., 1996), none display axonal morphologies similar to those of primary cultures, thus limiting 
their use in studying axonogenesis.   
Recently, Höke and colleagues created the 50B11 cell line by electroporating E14.5 rat 
primary DRG neurons to incorporate the SV40 large T-antigen and human telomerase reverse 
transcriptase. While these cells remain largely undifferentiated under standard culture conditions, 
in the presence of forskolin a significant proportion differentiate and undergo axonogenesis 
reminiscent of primary DRG neurons (Chen et al., 2007a).  These cells express other features in 
common with small diameter, nociceptor neurons including gene expression for some 
neurotrophin receptors and voltage-gated ion channels (Chen et al., 2007a).  Given their 
similarities to primary DRG neurons, 50B11 cells may hold promise as a model for studying 
axon growth.  However, DRG axonogenesis involves intricate interactions among trophic, tropic 
and modulatory factors acting on multiple receptors to regulate cytoskeletal structural protein 
expression, and it remains unclear how closely 50B11 cells replicate outgrowth regulatory 
mechanisms in primary neurons. In the present study, we show that differentiated 50B11 cells 
display phenotypes and responses to growth factors that are highly similar to those of DRG 
neurons. 
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MATERIALS AND METHODS 
Cell Culture, differentiation and treatments 
50B11 cells were a gift from Dr. Ahmet Hoke of the Johns Hopkins University.  Cells 
were plated onto plastic in 6 or 24 well tissue culture plates in Neurobasal medium (Life 
Technologies, Gibco) supplemented with FBS (Sigma-Aldrich), B27 (Life Technologies), 
glucose (Fisher) and glutamine (Sigma-Aldrich), as described previously (Chen et al., 2007a). 
Cells were plated at different densities including at low density to facilitate visualization of 
individual neuronal axon arbors, thus ensuring accurate measurements of neurite length. 24h 
after plating cells were differentiated by the adding forskolin (Sigma-Aldrich, 75 µM final 
concentration) to the medium. Based on observations by Chen et al. (Chen et al., 2007a) and our 
preliminary studies, we concluded that neuronal phenotype was most stable between about 20 
and 36h post-forskolin, and treatment protocols were designed to be completed within this time 
frame. 
Seventeen hours after initiating forskolin-induced differentiation, cells were treated with 
nerve growth factor (NGF, 50ng/ml recombinant mNGF, Peprotech), glial cell line-derived 
neurotrophic factor (GDNF, 50ng/ml recombinant hGDNF, Peprotech), estrogen (17β-estradiol, 
20 nM, Sigma-Aldrich) or angiotensin II (ANGII, 100 nM, Sigma-Aldrich). Cells were 
maintained for 20h and fixed with 4% paraformaldehyde.   
Immunostaining  
Cells were washed after fixation and incubated in blocking solution containing 1% BSA 
(Sigma-Aldrich), 5% normal donkey serum (Millipore), in phosphate buffered saline (Sigma-
Aldrich) containing 0.3% Triton X-100 (Sigma-Aldrich) for 1h at room temperature. They were 
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immunostained for PGP9.5 (1:700, rabbit antiserum, Serotec), βIII-tubulin (1:400, mouse 
antiserum, Millipore), peripherin (1:200, chicken antiserum Millipore), TrkA (1:200, rabbit 
antisera, Millipore), GFR alpha1 (1:200, goat antiserum, R&D Systems), GFR alpha2 (1:200, 
goat antiserum, R&D Systems), estrogen receptor (ER) alpha (1:200, rabbit antiserum, Santa 
Cruz Biotech), and ANGII receptor type 2 (AT2, 1:200, rabbit antiserum, Alamone Labs). 
Donkey IgG (1:200 to 1:400, Jackson Immunoresearch) tagged with Cy3 or Alexa 488 was 
directed against host primary antibodies. All antibodies were diluted in phosphate buffered saline 
containing 0.3% Triton X-100 and 5% normal donkey serum.  Primary and secondary antibody 
specificities have been confirmed using antibody preabsorption and omission controls in our lab 
and others (Baloh et al., 1998; Barker-Gibb et al., 2001; Chakrabarty et al., 2008; Chakrabarty et 
al., 2011; Tague et al., 2011).  
Quantitation of neurite outgrowth 
Individual neurons with distinct neurite arbors were visible in low-density cultures. For 
each treatment group in each experiment, 75-100 individual neurons were imaged. Neurons were 
counted from randomly collected images (about 15-20 per well). Single neurons with minimal or 
no overlap of neurite arbors with adjacent cells were analyzed for neurite outgrowth using NIH 
ImageJ software with the NeuronJ Plugin.  The distances from the soma perimeter to the tips of 
each axon extension were measured by tracing the arbors; data were expressed as the summed 
length of outgrowth within the arbor and as the maximum length of the longest axon. Treatment 
effects were compared by Mann-Whitney rank sum tests.  
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RESULTS 
Characterization of axonal markers in differentiated 50B11 cells  
Following forskolin differentiation, 50B11 cells acquire many phenotypic features 
characteristic of DRG neurons, including expression of the cytoskeletal proteins βIII-tubulin and 
the hypophosphorylated form of neurofilament H in axon-like processes (Chen et al., 2007a).  
We further characterized these cells to more fully assess their content of other cytoskeletal 
proteins typical of DRG neurons.   
50B11 cells immunostained 20h after forskolin confirmed the presence of βIII-tubulin, 
which was most intense in the cell body and fainter in the axons (Fig. 1A).  PGP9.5 is a ubiquitin 
hydrolase expressed in all intact axons (Lundberg et al., 1988) and has been used extensively for 
staining nerve fibers both in vitro and in vivo (Wilkinson et al., 1989). PGP9.5 immunostaining 
was intense within the cell body, but was also bright throughout the axons, allowing us to resolve 
much finer details of the processes (Fig.1B). PGP9.5 showed consistent colocalization with βIII-
tubulin within differentiated cells (Fig. 1C) and with lower expression in undifferentiated 50B11 
cells. 
Peripherin is a type III intermediate filament protein that is a selective marker for 
unmyelinated axons in vivo and in vitro (Fuchs and Weber, 1994; Fornaro et al., 2008).  
Immunostaining of differentiated 50B11 cells showed expression that was largely restricted to 
the soma (Fig. 1D). Peripherin expression was weak in undifferentiated cells. 
When stained for PGP9.5, cultures plated at densities allowing identification of 
individual axonal arborizations revealed a range of morphologies, with cells generally extending 
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2 or 3 neurites (Fig. 1B) but occasionally as many as 4 or more as described previously (Chen et 
al., 2007a). 
Receptor expression in 50B11 cells 
Differentiated 50B11 cells resemble small diameter nociceptive DRG sensory neurons 
and express mRNA for trkA, p75, c-RET, and GFR alpha1 (Chen et al., 2007a).  In vivo, DRG 
nociceptive neurons are often categorized into distinct subclasses based on expression of NGF or 
GDNF-family receptors (Molliver and Snider, 1997; Molliver et al., 1997). We performed 
immunocytochemistry to localize trkA, GFR alpha1 and GFR alpha2 receptor subtypes in these 
cells. Differentiated 50B11 cells express all these receptor subtypes (Fig. 2A, B, E, F). However, 
co-localization showed that all cells express both the NGF and GDNF-family receptors (Fig. 2C 
& G) and cannot be subdivided based on unique receptor expression.  
In addition to neurotrophins, other agents such as hormones affect axon outgrowth in 
primary DRG neuron cultures. ANGII for example enhances DRG axon growth by signaling 
through the AT2 receptor (Chakrabarty et al., 2008).  AT2 expression in DRG neurons is 
upregulated by estrogen acting on ER  alpha, which also increases axonal growth (Chakrabarty et 
al., 2008).  We investigated expression of AT2 and ER alpha in differentiated 50B11 cells.  At 
24h after forskolin-induced differentiation, 50B11 cells showed AT2 receptor immunoreactivity 
throughout the soma extending into the neurites (Fig. 2D); undifferentiated cells weakly 
expressed AT2.  Differentiated 50B11 cells also showed prominent expression of ER alpha 
which was localized to the cell nucleus; ER alpha expression was low or absent in 
undifferentiated cells (Fig. 2H).  
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NGF and GDNF promote axon outgrowth in 50B11 cells 
50B11 cells express neurotrophin receptors, and their gene expression is regulated by 
NGF and GDNF (Chen et al., 2007a). We quantified axon outgrowth in response to these 
neurotrophins.  Twenty h following NGF treatment, total neurite outgrowth was increased by 
about 21% (Fig. 3A, p≤0.001), while the length of the longest neurite was increased by about 
44% (Fig. 4A, p≤0.001).  GDNF also increased outgrowth by 23% and 51%, respectively (Figs. 
3B, 4B, p≤0.001). The increased outgrowth in response to both neurotrophic factors was 
statistically comparable. 
Angiotensin II and estrogen promote axon growth in 50B11 cells 
AT2 receptor activation promotes axon growth by DRG nociceptor neurons in vivo and in 
vitro (Chakrabarty et al., 2008) and 50B11 cells express receptors for both AT2 and estradiol, 
which upregulates AT2. Addition of ANGII at concentrations optimal for increasing outgrowth 
in primary DRG cultures (Chakrabarty et al., 2008) increased total arbor length by 27% (Fig. 3C, 
p≤0.001) and length of the longest neurite by 28% (Fig. 4C, p≤0.001). 50B11 cells also 
responded to E2 by increasing total arbor length by about 15% (Fig. 3D, p≤0.001) and length of 
the longest neurite by 25% (Fig. 4D, p≤0.001) at a concentration optimal for DRG neurite 
outgrowth (Chakrabarty et al., 2008). The effects of both E2 and ANGII on total outgrowth and 
longest axon length were comparable.  Similarly, both agents produced increases in overall 
outgrowth that were comparable to those induced by NGF and GDNF.  However, neurotrophins 
were more effective than ANGII in augmenting maximum axon length (NGF vs ANGII, p=0.03; 
GDNF vs ANGII, p=0.002); while NGF was comparable to E2 in increasing maximum axon 
length, GDNF was more effective than E2 (p=0.004). 
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DISCUSSION 
The utility of the 50B11 cells in studying neurodegeneration has been previously noted 
(Chen et al., 2007a; Melli and Hoke, 2009) and the present study extends these findings to 
demonstrate their potential in studying axonal outgrowth.  Axon growth and maintenance are 
dependent upon specific cytoskeletal proteins, many of which can be used as selective markers.  
βIII tubulin is one of the most extensively used neuron-specific markers for axon/neurite staining 
and quantification of primary neurons both in vitro and in vivo (Feit et al., 1971; Guo et al., 
2010; Guo et al., 2011). In differentiated 50B11 cells, we observed intense βIII-tubulin 
immunostaining within the cell body and proximal neurites but less intense staining in the more 
distal regions of the neurite. It is unclear if this is because βIII-tubulin distribution in 50B11 cells 
differs from that of primary neurons or is attributable to the culture conditions.  Thus, the post-
treatment interval for working with stably differentiated 50B11 cells is comparatively short, and 
since βIII-tubulin populates the axon relatively late as compared to actin, it is possible that 
microtubule content had not yet reached its maximum when our samples were prepared.  
Peripherin immunoreactivity was also abundant in the cell body, providing further 
evidence that the 50B11 cells display a phenotype consistent with sensory nociceptors.  
However, fluorescence intensity was insufficient to fully elucidate axons.  This may again reflect 
culture duration; cytoskeletal integration of this intermediate filament protein lags behind tubulin 
in growing DRG axons, and peripherin is a relatively late arrival to distal regenerating axons 
(Goldstein et al., 1991).  
In contrast, differentiated 50B11 cells showed high levels of PGP9.5 throughout the 
soma, axons and terminal neurites. PGP 9.5 (ubiquitin carboxy-terminal hydrolase L1) is a 
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neuron-specific ubiquitin hydrolase and a member of a large family of deubiquinating enzymes 
(Day and Thompson, 2010).  Although specific functions of this protein are not fully clear, it is 
believed to play a role in cleavage of either ubiquitin-protein bonds or C-terminal extensions of 
ubiquitin itself. The high turnover rate for protein in neuronal cells, and particularly in the 
growing tips of neurites, actively involves the ubiquitin-proteasome pathway (Tai and Schuman, 
2008) which has been implicated in a number of neuronal functions including outgrowth, 
synaptic transmission, and plasticity (Yi and Ehlers, 2007).  Indeed, PGP9.5 comprises some 5-
10% of the cytoplasmic protein in primary neurons (Day and Thompson, 2010), and apparently 
high levels are also retained in 50B11 cell, including within the terminal neurites.  Accordingly, 
not only do 50B11 cells express this neuron-specific protein at high levels, but it is a useful 
marker for visualizing neurite extension by differentiated cells. 
In postnatal mouse DRG it is possible to detect distinct populations of small-diameter 
neurons based on their neurotrophin dependencies; some are dependent upon NGF for survival, 
while others require members of the GDNF family of proteins (Priestley et al., 2002).  Chen et 
al. showed it was possible to detect mRNA encoding NGF and GDNF receptors from 
differentiated 50B11 cell cultures (Chen et al., 2007a), and our immunofluorescence studies 
show that 50B11 cells synthesize NGF and GDNF receptor proteins.  However, we also show 
that both receptors are co-expressed in differentiated 50B11 cells.  This may not be altogether 
surprising given that 50B11 cells were derived from d14.5 embryonic DRG neurons. At this 
stage of development, migration of neural crest cells forming the DRG is largely complete and 
the cells have undergone preliminary differentiation (Marmigere and Ernfors, 2007).  All small 
neurons at this stage are positive for trkA. Subsequently, under the influence of the Runx1 
transcription factor, some cells lose trkA and acquire Ret expression, with these 2 populations 
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differentiating into mature ‘peptidergic’ (i.e., calcitonin gene-related peptide-positive) and ‘non-
peptidergic’ (isolectin IB4-positive) populations (Marmigere and Ernfors, 2007). It appears that, 
in the process of immortalizing embryonic DRG neurons, the normal developmental program 
may have been altered such that all resulting cells ultimately express both receptor types. It 
should be noted that mRNAs encoding NGF and GDNF receptors are widely colocalized in DRG 
neurons of the adult rat (Kashiba et al., 2003) and our findings suggest that differentiated 50B11 
cells also show a neurotrophin receptor profile that may reflect responsiveness to both families of 
neurotrophic proteins. 
A question unanswered is whether DRG neurons expressing both NGF and GDNF 
receptors can respond to both types of neurotrophic factors.  Our studies examining axonal 
architecture show that, at least in differentiated 50B11 cells, both pathways are capable of 
inducing axon outgrowth.  Thus, both NGF and GDNF increased total arbor length and the 
length of the longest axon to comparable extents.   
Many factors in addition to classical neurotrophins influence axonal growth.  In the case 
of DRG nociceptor neurons, there is accumulating evidence that these cells can be strongly 
influenced by local or systemic hormonal factors.  For example, sustained elevation of plasma 
estrogen in vivo results in increased sensory nociceptor innervation of the skin, mesentery, and 
mammary gland in rats (Blacklock et al., 2004; Blacklock and Smith, 2004).  Estrogen acts on 
nociceptor ER alpha to increase levels of AT2 mRNA and protein. AT2 mediates the 
neuritogenic effects of the hormone ANGII, which is derived from autocrine or paracrine sources 
(Chakrabarty et al., 2008).  Our findings show that differentiated 50B11 cells, like DRG 
nociceptors neurons, express both AT2 and ER alpha receptors, consistent with potential 
hormonal modulation of these cells. 
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The AT2 receptor and ER-alpha appear to function comparably in both 50B11 cells and 
DRG nociceptors neurons.  Hence, peripherin-positive DRG neurons show enhanced neurite 
outgrowth when primary cultures are treated for 48-72h with either estrogen or ANGII, and the 
present studies show that both agents are equally effective in inducing 50B11 cell neurite 
outgrowth.  It is noteworthy that neither ANGII nor estrogen promoted outgrowth to the extent 
obtained with either NGF or GDNF.  In contrast, in primary neonatal DRG cultures, estrogen 
was more effective in eliciting outgrowth than was NGF (Blacklock et al., 2005).  It is unclear if 
this is due to intrinsic differences between 50B11 cells and DRG neurons, or if 50B11 cells, 
which derive from much younger neurons, retain a greater sensitivity to NGF which has been 
downregulated in the neonatal neurons.  Nonetheless, it is clear that 50B11 cells respond to 
hormones and neurotrophic factors in a manner that is qualitatively comparable to that of native 
DRG nociceptors neurons. 
Thus from the present study, some significant conclusions can be drawn. Alterations in 
peripheral sensory innervation are strongly associated with many pathological conditions, such 
as peripheral neuropathies where sensory axons are lost (McLeod, 1995; Low and Cheng, 2005; 
Luo and O'Leary, 2005; Saxena and Caroni, 2007), and chronic inflammatory pain syndromes 
characterized by nociceptor axon proliferation (Di Sebastiano et al., 1995; Masheb et al., 2000; 
Alfredson et al., 2003; Tympanidis et al., 2003; Schubert et al., 2005).  Therefore, signaling 
pathways responsible for regulating nociceptor axonal architecture are attractive targets for 
therapeutic intervention to either increase or decrease outgrowth as appropriate. To date, the 
intracellular signaling proteins and their interactions remain incompletely understood, and we 
lack effective tools to modify outgrowth, in part because of the difficulty in conducting high-
throughput screening on primary neuronal cultures. We show here that 50B11 cells constitute a 
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robust assay system for assessing neurite outgrowth in vitro.  Moreover, these cells respond to 
trophic factors and hormones in a manner that is largely indistinguishable from DRG neurons.  
These findings provide strong validation for the idea that differentiated 50B11 cells provide a 
useful tool for investigating mechanisms regulating nociceptor axon outgrowth. 
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FIGURES 
 
Figure 1. 
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Figure 1.  Differentiated 50B11 cells show cytoplasmic proteins characteristic of DRG neurons.  
A. Staining for βIII-tubulin is prominent in the cell body but diminished in distal processes. B.  
PGP9.5 immunostaining delineates both soma and axons in good detail. C. An overlay of A and  
B shows colocalization of these neuronal markers. D. Peripherin immunohistochemistry shows  
strong expression in the soma but little in processes.  Bar in E=50µm for all panels. 
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Figure 2. 
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Figure 2. Expression of growth factor receptors by 50B11 cells. Cells were differentiated for 20h  
and then fixed and stained for receptor proteins. A. All cells showing neuron-like morphologies  
after differentiation showed immunostaining for the NGF receptor, trkA. B. Cells also showed  
strong immunoreactivity for the GDNF receptor, GFR alpha1. C. A merged image shows that all 
differentiated neuron-like cells express both trkA and GFR alpha1. D. Differentiated cells also 
show immunoreactivity for the ANGII receptor, AT2.  E. TrkA staining of differentiated cells.  
F.  Immunostaining of the same field as E shows cells uniformly expressing GFR alpha2. G. A 
merged image of E and F shows colocalization of trkA and GRF alpha2. H. Differentiated, 
tubulin beta III positive cells display predominantly nuclear immunoreactivity for estrogen 
receptor alpha whereas undifferentiated cells display little or no ER alpha. Bar in D =50µm for 
all panels. 
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Figure 3. 
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Figure 3. Both neurotrophic and hormonal factors increase total neurite length in differentiated  
50B11 cells. Total length of all processes emerging from each differentiated neuron 20h after  
treatment were summed and compared to untreated controls. A. Treatment with 50 ng/ml  
Nerve Growth Factor (NGF) increased axon length. B. Treatment with 50 ng/ml Glial Derived  
Neurotrophic Factor (GDNF) also increased total outgrowth from 50B11 cells to an extent  
similar to NGF. C. Angiotensin II (AngII) at 100mM concentration increased total neurite  
length. D. Estrogen (E2) at a concentration of 20nM also increased total axon arbor length.  
*P≤0.001 vs. Control. 
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Figure 4. 
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Figure 4. Neurotrophins and hormones increase length of the longest neurite in differentiated  
50B11 cells. The length of the longest neurite from each cell was measured 20h after treatment.  
A. NGF (50 ng/ml) increased maximum neurite length. B. GDNF (50ng/ml) also increased  
axonal length. C. AngiotensinII (AngII, 100mM) increased maximum neurite length. D.  
Estrogen (E2, 20nM) induced significantly longer axons in treated neurons as compared to  
controls. *P≤0.001 vs. Control 
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Chapter 4. Mechanisms of Bone Morphogenetic Protein 4 mediated sensory axon plasticity 
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ABSTRACT 
Bone Morphogenetic Protein 4 (BMP4) can induce axonal growth in adult peripheral 
sensory neurons of the dorsal root ganglia (DRG) not only following injury, but also under 
physiological conditions. Outgrowth is associated with phosphorylation and nuclear translocation 
of Smad1. We investigated the signaling mechanism by which BMP4 induces outgrowth. BMP4 
can activate the helix-loop-helix transcription factor Inhibitor of DNA-2 (Id2) downstream of 
Smad1, which has been previously indicated in axonal growth-regulation in developing central 
nervous system (CNS). We found that BMP4 and also several other trophic factors upregulated 
Id2 in the 50B11 sensory neuronal cell line preceding onset of outgrowth. Overexpression of Id2 
in 50B11 cells significantly increased neurite outgrowth even in basal media in absence of any 
trophic factors. Lentiviral knockdown of Id2 in dissociated DRG neurons decreased outgrowth 
significantly. However, Id2 knockdown failed to completely abrogate outgrowth induced by 
BMP4 indicating possible involvement of other BMP4-induced factors. We found that Methyl 
CpG binding Protein 2 (MeCP2), a methylated-DNA binding protein and a global transcriptional 
repressor, known to highly express in neurons, is downregulated by BMP4 in 50B11 cells. From 
separate studies, MeCP2 is also known to downregulate Id2 transcription. It is widely accepted 
that induction of outgrowth in a mature quiescent adult neuron is associated with transcriptional 
reactivation of a large number of factors otherwise dormant since development. We observed 
that MeCP2 is highly expressed in DRG neurons of adult rats both in vitro and in vivo. BMP4 
downregulated MeCP2 expression levels in primary neurons when treated in vitro. When MeCP2 
was knocked down by lentiviral shRNA delivery, neurite outgrowth in primary DRG culture 
increased dramatically. BMP4 treatment of MeCP2 knocked down neurons failed to elicit any 
further increase of outgrowth. Thus BMP4 potentially induces axonal growth in the adult sensory 
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neuron by downregulating MeCP2 to bring about a global transcriptional upregulation inducing 
multiple genes essential for rekindling outgrowth.  
INTRODUCTION 
In order to start growing its axons again, a mature adult neuron needs to reactivate 
specific transcriptional programs, much of which has stayed dormant since after development 
(Mechaly et al., 2006; Patodia and Raivich, 2012b, a). Such transcriptional rekindling can be 
achieved by inflicting a mechanical axonal injury. Peripheral axon injury activates a host of 
signaling molecules and several transcription factors (TFs). Activating transcription factor 3, 
AP1 family of transcription factors (c-Jun/Jun D), cAMP response element binding protein 
(CREB), STAT3 etc. are examples of few transcription factors that activate (phosphorylate) and 
translocate to the nucleus upon axotomy (Patodia and Raivich, 2012a). These TFs induce genes 
essential for axonal growth, membrane trafficking, cell adhesion, cytoskeletal dynamics etc. that 
are critical for elongation (Mechaly et al., 2006; Szpara et al., 2007). 
However, in parts of the peripheral nervous system, spontaneous structural changes in 
axons continue to occur through adult life even in absence of any injury. Plasticity and axon 
growth is often driven by local functional requirements (eg. different parts of the female 
reproductive tract, mammary gland, vascular system etc.) or disease state (e.g., musculo-skeletal 
hyperinnervation in vitamin D deficiency, hyperinnervating pain syndromes, inflammatory pain 
etc.) in specific tissues or organs (Tympanidis et al., 2003; Blacklock et al., 2004; Blacklock and 
Smith, 2004; Ting et al., 2004; Chakrabarty et al., 2011; Tague et al., 2011).  Although traumatic 
injury has been the most popular model to study axon growth in adult neurons, innervation 
changes in most human diseases ensue in undamaged axons, often under physiological 
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conditions. However, little is known about the cellular mechanisms that initiate outgrowth in 
intact peripheral axons.  
It has only been recently known that Smad1 is a unique transcription factor that can 
modulate outgrowth not only following injury, but also in intact peripheral sensory axons under 
physiological conditions. Smad1 is activated by BMP4 and induces outgrowth in axotomized 
neurons in vitro and in vivo (Zou et al., 2009; Parikh et al., 2011). We recently found that BMP4 
can induce outgrowth via Smad1 activation, in intact sensory axons. In the female reproductive 
tract, sensory axons sprouted with increase in BMP4 levels in a Smad1 dependent manner to 
increase innervation density in the vagina (Bhattacherjee et al., 2013). While knockdown of 
Smad1 abrogates outgrowth, it remains unknown what events in the nucleus, downstream of 
Smad1 activation, leads to outgrowth initiation (Zou et al., 2009). 
In non-neural cells, Smad1 can induce Id (Inhibitor of DNA binding) family of 
transcription factors comprising of four members from Id1 through Id4 (Miyazawa et al., 2002). 
In the developing central nervous system, level of Id2 is very high in the maturing neuronal cell 
during its phase of active axon extension (Lasorella et al., 2006). Id2 is rapidly degraded as the 
axon reaches target and extension ceases (Jackson, 2006; Lasorella et al., 2006). Does Smad1 
recapitulate this developmental phenomenon in the peripheral neurons to induce outgrowth via 
Id2 upregulation? Growing evidence suggests that Smad1 is capable of regulating a wide 
landscape of transcriptional networks by inducing multiple TFs downstream (Massague et al., 
2005; Miyazono et al., 2010). Delicate balance of these regulatory networks is often involved in 
major decisions such as fate determination of differentiating cells (Massague et al., 2005). In this 
study we investigated the mechanism by which BMP4 induces sensory axon outgrowth 
downstream of Smad1 activation. 
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MATERIALS AND METHODS 
All animal protocols and procedures were approved by the Kansas
 
University Medical 
Center’s Animal Care and Use Committee
 
and were in accordance with the National Institutes of 
Health
 
guidelines for the care and use of laboratory animals.
 
 
Culture and treatment of 50B11 cells 
50B11 cells were cultured in 24 well plates using previously described defined media () 
at about 50-60% density and differentiated with 75µm forskolin 24h after plating. At 17h 
following onset of differentiation cells were treated respectively with: 20nM 17β estradiol 
(Sigma-Aldrich), 100nM Angiotensin II (Sigma-Aldrich), 50ng/ml recombinant mouse Nerve 
Growth Factor (NGF, Peprotech), 50ng/ml recombinant mouse BMP4 (Peprotech). Cells were 
washed and harvested for RNA isolation at 6h and 12h time points. 
RNA isolation and PCR 
For RNA isolation from cells cultured in 24 well plates, media was removed and 500µl 
Trizol (Invitrogen) was added to each well and mixed by pipetting up and down few times. RNA 
was isolated from this lysate following the standard chloroform/ isopropanol extraction method. 
cDNA was synthesized from 1µg of total RNA using Superscript II Reverse Transcriptase 
(Invitrogen) using random primers (Invitrogen), dNTP (Fermentas) according to the 
manufacturer’s protocol. Quantitative RT-PCR was performed using iQ SYBR Supermix 
(BioRad). Primers used (5’-3’): Id2 - (Forward: AGAGACCTGGACAGAACC; Reverse: 
CGCATTTATTTAGCCACAGAG); GAPDH (Forward: CTCTACCCACGGCAAGTT; 
Reverse: CTCAGCACCAGCATCACC).  
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Immunoblots  
To assess protein levels of Id2 and MeCP2, cell lysates from 50B11 cells and primary 
dissociated DRG cultures with relevant treatments or overexpression/knockdown were harvested 
in ice-cold RIPA lysis buffer. About 50-75µl of lysis buffer was used for each well of 24 well 
plate. About 15-40µg total protein is loaded per well and separated on a 12% or 4-12% 
polyacrylamide gel, transferred to a PVDF membrane and probed with anti-Id2 (rabbit 
polyclonal antibody, Sigma,1:500) or anti-MeCP2 (rabbit monoclonal antibody, Cell Signaling 
Tech, 1:1000) and reprobed for beta-actin (Sigma, 1:1000) or GAPDH (Millipore, 1:1000).   
Cloning and Transfection 
For Id2 overexpression, full length rat Id2 cDNA was cloned into the pcDNA3 
(Invitrogen) expression vector.  Rat trophoblast stem cells express high Id2 levels. Total RNA 
from trophoblast stem cell culture (a kind gift from Ms. Damayanti Chakraborty of Soares Lab at 
KUMC) was reverse transcribed using SuperScript II reverse transcriptase (Invitrogen) using 
manufacturer’s protocol. Full length Id2 from this cDNA was PCR cloned into the pcDNA3 
expression vector between the BamHI and XbaI restriction sites. Fast Digest enzymes 
(Fermentas) were used for restriction of the vector and insert and ligation was performed for 1h 
at room temperature using T4 DNA ligase (Fermentas). Competent E. coli (NEB Turbo® from 
New England Biolabs or XL10Gold from Agilent) were transformed with ligation mix, cultured 
at 37
o
C for an hour (in SOC or NZY broth respectively) with shaking and plated on ampicillin 
plates (50-100µg/ml) for overnight incubation at 37
o
C. Isolated colonies were picked and 
cultured next day and PCR screened. Minipreps were done for clones with inserts and DNA was 
sequenced using primers for the CMV promoter to confirm correct insertion and sequence of Id2.  
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 The prepared plasmid was then transfected into 50B11 cells that had been split and plated 
day before, using Lipofectamine 2000 (Invitrogen) following the manufacturer’s protocol. The 
control group was transfected with the empty pcDNA3 vector. Transfection media (Opti-MEM, 
Invitrogen with 5% FBS, Sigma) was replaced after 6-8h with complete 50B11 culture medium 
as described before. After 24h fresh medium was added to the cells with geneticin (Gibco, Life 
Technologies) selection at doses of 200, 400, 600 and 1000mg/ml. It takes 24-48 h for selection 
to occur. Cells with the highest compatible dose were selected (600mg/ml) and medium was 
changed with equivalent dose of the antibiotic and maintained. The selected cells were 
subsequently used in experiments with geneticin free defined 50B11 culture media. 
Lentivirus production and transduction 
Five to seven candidate shRNAs, commercially available from Sigma in the pLKO1 
lentiviral vector backbone (from Addgene, with puromycin selection cassette) directed against 
mouse or human genes (Id2 or MeCP2) were first selected for each gene on the basis of 100% 
sequence homology with the rat counterparts. Using these lentiviral particles were synthesized 
239T cells and 50B11 cells were infected with these as well as the scrambled shRNA control in 
the same vector. After puromycin selection, percent gene knockdowns were assessed at the RNA 
and protein levels. The shRNA with the highest efficiency of knockdown was selected for study. 
This shRNA was then cloned out by PCR from the pLKO1 vector along with its promoter and 
cloned into the FG12 lentiviral vector (Addgene) between XbaI and PacI restriction sites. The 
vector carries an EGFP reporter under a ubiquitin-C promoter. Third generation lentiviral 
packaging with pMDLg/RRE, pRSV-Rev, and pMD2.G (Addgene) was used to synthesize 
lentiviral particles for BMP4 and EGFP-only vectors.  293T cells were plated in 6 well plates at 
60-80% confluence and transfected with the vector carrying the gene of interest or EGFP alone 
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and all the 3 packaging plasmids using Lipofectamine 2000 (Invitrogen, Life Technologies) in 
Opti-MEM medium (Gibco, Life Technologies). Medium was changed 12h later with 
OptiMEM-5%FBS and supernatant collected every 24h for 2-3 days. This supernatant was used 
for transducing primary neuronal cultures plated in 24 well plates with 80µl per well in 500µl 
medium. If necessary, viral particles were concentrated from the supernatant by 
ultracentrifugation in sealed tubes for 2h at 35000 rpm and resuspended in sterile PBS. Lentiviral 
titers were measured using the Lentivirus qPCR titer kit (Applied Biological Materials).  
Primary neuronal culture 
Lumbosacral DRGs from 5 to 6-week-old female rats were harvested and dissociated 
following previously described protocols. Briefly, the ganglia were isolated and placed in ice-
cold L15 medium containing 3% glucose.  They were chopped into pieces and incubated at 37
o
C 
in 1% collagenase (Sigma-Aldrich) and 2.4u dispase (Worthington) in HBSS (Sigma-Aldrich). 
After 40mins, enzyme was removed and DRG chunks were neutralized with L-15/10% FBS and 
triturated using fire-polished glass pipettes to complete dissociation. The suspension was passed 
through 100µm nylon strainer (BD Biosciences) and then centrifuged through a percoll (Sigma-
Aldrich) column to remove undissociated chunks and myelin debris. The pellet was washed in 
L15-FBS to remove any percoll and resuspended in complete Neurobasal A medium (Gibco) 
supplemented with B27 (Gibco), glutamine (Sigma-Aldrich), Primocin (Invivogen) and 10% 
FBS as described before. Neurons were plated at a low density onto laminin/poly-D lysine pre-
coated 24 well plates (BD Biosciences) in 500µl media per well. Neurons to be transduced with 
lentivirus were directly plated with polybrene (Sigma-Aldrich) and viral supernatant was added 
after 1h. After 24h medium was changed to serum-free Neurobasal  A containing glutamine and 
B27, now supplemented with uridine and fluorodeoxy-uridine (Sigma-Aldrich) to inhibit glial 
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proliferation (1ml medium/well).   In treatment groups, 50 ng/ml mouse recombinant BMP4 
(Peprotech) was added during this medium change at 24h.  After 48h from plating, cultures were 
fixed with 4% formaldehyde and washed with PBS. Cultures were immunostained for markers 
like tubulin βIII, peripherin, GFP. 
To quantify neurite outgrowth, about 80-100 EGFP positive isolated neurons were 
randomly imaged from 3-4 wells per treatment group using a 10X objective. Total length of 
outgrowth per neuron was quantified by tracing using the NeuronJ application module of NIH 
ImageJ. 
Immunohistochemistry 
Dissociated primary neuronal cultures and 50B11 cells were fixed with 4% PFA at the 
end of culture for 20mins. Cells were then washed with PBS blocked in host serum and subjected 
to primary antibody incubation overnight (further details below). For staining of the dorsal root 
ganglia animals were euthanized by thoracotomy under isofluorane anesthesia and lumbo-sacral 
dorsal root ganglia (DRG) harvested and fixed by overnight immersion in 4% PFA at 4˚C and 
cryosectioned at 14 µm as described previously (Chapter 2).  
Cultures and sections were blocked in 5% primary host serum with 1% BSA in PBST and 
immunostained overnight for peripherin (1:400, rabbit antiserum; 1:500, chicken antiserum, 
Millipore), Tubulin βIII (1:400, mouse antiserum, Chemicon/Millipore), calcitonin gene-related 
peptide (CGRP,1:400, sheep antiserum, Biomol), Enhanced Green Fluorescent Protein (EGFP, 
1:750, chicken antiserum, Aves), Methyl CpG binding Protein 2  (MeCP2, 1:200, rabbit 
monoclonal antibody, Cell Signaling Technologies), Id2 (1:200, rabbit antiserum, Sigma-
Aldrich).  Secondary antibodies included donkey anti-rabbit Cy3 at 1:200 (Jackson Immuno-
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Research), donkey anti-mouse Cy3 (1:200, Jackson Immuno-Research), donkey anti-rabbit 
Alexa 488 (1:750, Invitrogen), donkey anti-rabbit Alexa 647 (1:500, Invitrogen), donkey anti-
chicken Dylight 488 (1:750 Invitrogen), donkey anti-goat Cy3 (1:200 Jackson Immuno-
Research), and donkey anti-sheep Cy3 (1:200 Jackson Immuno-Research).  Antibodies have 
been previously characterized by our laboratory and others (Abir et al., 2008; Clarke et al., 2010; 
Tague et al., 2011; Tague and Smith, 2011) and include omissions of primary and secondary 
antibodies. 
Statistical analysis 
All values are presented as mean ± SEM. Comparisons between groups were made using 
Student’s t-test, one-way ANOVA, or two way ANOVA with post-hoc comparisons by Student 
Newman-Kuels tests for normally distributed data, and Mann-Whitney rank sum test for non-
parametric analysis. Paired t-tests were used to compare innervation densities in injected and 
non-injected sites within the same animals in the lentiviral studies. Differences were considered 
significant at P≤0.05. 
 
RESULTS 
Multiple growth promoting factors induce transient Id2 upregulation in 50B11 cells 
50B11 cells are a neuronal cell line generated from 14.5d embryonic rat DRG neurons 
(Chen et al., 2007a). We and others (Chen et al., 2007a; Melli and Hoke, 2009) have previously 
shown that multiple factors, including both canonical and non-canonical neurotrophic factors, 
induce increased neurite outgrowth in these cells. The responses closely represent that of primary 
DRG neurons in vitro. We treated differentiated 50B11 cells with BMP4 to see whether it 
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induced upregulation of Id2. Cells were also treated with a set of other growth factors known to 
promote outgrowth, to investigate potential association of Id2 with neurite growth. Total RNAs 
were isolated from control and different treatment groups 6h following treatment and Id2 
expression was assessed by qRT-PCR. Treatment of 50B11 cells with BMP4 induced 
upregulation of Id2 levels by about 3 folds compared to control (Fig.1). Other growth promoters 
like estrogen (E2), angiotensin II (AngII) and nerve growth factor (NGF) induced increase in 
relative Id2 levels by almost 2 fold (Fig.1). These indicate a potential role of Id2 in neurite 
growth, requiring transient upregulation of the transcription factor at the time outgrowth 
initiation. 
Overexpression of Id2 in 50B11 cells induced increased neurite outgrowth 
To determine the effect of Id2 on neurite outgrowth and neurite length, we overexpressed 
Id2 in 50B11 cells. Full length rat Id2 cDNA was reverse transcribed from rat trophoblast stem 
cell (known to express high Id2 levels) total RNA and PCR cloned into the pcDNA3 expression 
vector (Fig. 2A). In pcDNA3 gene expression is driven by the CMV promoter and the vector 
contains a neomycin/geneticin selection cassette. 50B11 cells were transfected either with 
pcDNA3 containing the full length Id2 cDNA or with the empty vector for control and were both 
selected at the similar dose (1mg/ml) of geneticin (starting at 48h from transfection; selection 
was started at 400µg/ml and then gradually increased). Elevated expression of Id2 was observed 
in 50B11 cells transfected with the cDNA (~5 fold mRNA increase, data not shown) compared 
to the empty pcDNA3 transfection (Fig. 2B). Upon forskolin (a plant derived diterpene 
compound that is a potent inducer of adenylyl cyclase that can increase intracellular levels of 
cAMP) induced differentiation, the Id2 overexpressing cells extended longer neurites than the 
control cells (Fig. 2C). The basal total length of outgrowth per neuron increased significantly in 
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presence of high Id2. BMP4 at 50ng/ml induced significantly elevated outgrowth in control cells 
(Fig. 2D). In Id2-overexpressing cells total outgrowth was not elevated any further with BMP4 
treatment (Fig. 2D).  
Knockdown of Id2 in primary DRG neuron in vitro downregulated neurite outgrowth 
To determine the necessity of Id2 in outgrowth we then performed shRNA mediated Id2 
gene knockdown in primary DRG neurons in vitro using lentiviral delivery. Candidate shRNAs 
were screened to find the highest efficiency of knockdown. Screening was performed in the 
50B11 cells with delivery of the shRNA in the pLKO1 vector backbone with puromycin 
selection. 
A shRNA with 88% efficiency of knockdown was selected (Fig. 3B). This sequence was 
cloned into the FG12 lentiviral vector backbone which expresses EGFP but has no antibiotic 
selection (Fig. 3A). Primary DRG neuronal cultures prepared from young adult rats (about 40d 
old) were infected with lentivirus carrying expression of either scrambled shRNA for control or 
shRNA for Id2 knockdown at the time of plating (Fig. 4A-F). Culture medium was changed to 
fresh basal media 24h after plating. Cells were fixed after another 24h (i.e. 48h from plating) and 
stained for tubulin-βIII. About 80-100 EGFP expressing neurons per group were imaged 
randomly from 3 replicate wells and length of total outgrowth was estimated by tracing using the 
NeuronJ application module of the NIH ImageJ program (Fig. 4 A-F). Results showed that 
downregulation of Id2 induced a significant reduction of basal outgrowth in DRG neurons in 
culture (Fig. 4G). 
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Id2 knockdown failed to abrogate BMP4 induced increase in neuronal outgrowth 
To validate the hypothesis that BMP4 induced outgrowth in DRG neurons is mediated by 
Id2, we treated Id2-knockdown neurons with BMP4. A similar protocol for culture, virus 
infection and fixation was followed as above. Treatment was given at the time of medium 
change, 24h after plating and virus infection. In control (with scrambled shRNA) BMP4 induced 
significant increase of total neurite outgrowth per neuron. In the Id2 knockdown group BMP4 
also induced a significant increase of neurite outgrowth, which is slightly lower than the effect 
on the scrambled group, but is not significantly different (Fig. 5).   
DRG neurons show high levels of MeCP2 expression 
Our findings so far indicate that BMP4 induces increase in Id2 expression as well as 
increased neurite outgrowth in sensory neurons. While Id2 may contribute to BMP4 mediated 
outgrowth, it appears that there could be additional factors induced downstream of Smad1 that 
are required for successful outgrowth and can compensate for the absence of Id2. Furthermore, 
when activated, Smad1 can induce multiple factors as observed in other cells (rather than 
functioning through a single transcription factor) (Massague et al., 2005).  
Methyl CpG-binding Protein2 (MeCP2) is a DNA binding protein that can bind to 
methylated DNA, usually found heavily in gene promoters and act as a structural and function 
modifier of chromatin (Meehan et al., 1992; Nan et al., 1993; Becker et al., 2013). In association 
with other co-repressors, MeCP2 can act as a global repressor affecting expression of multiple 
genes at the same time (Nan et al., 1997; Nan et al., 1998a; Chandler et al., 1999). Recently, 
MeCP2 has been shown to regulate expression of all members of the Id family of genes in CNS, 
including Id2 (Peddada et al., 2006). Also, it is observed, that cells receiving high levels of 
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BMP4 signals, like embryonic stem cells, show relatively low expression of MeCP2. Expression 
of MeCP2 is very high in neurons of the adult CNS (Kaufmann et al., 2005). To investigate 
whether MeCP2 could be a potential downstream effector of BMP4 signaling, we first analyzed 
expression of the protein in sensory neurons of the DRG.  
Lumbar DRGs of the L4-L6 levels from adult rats aged between 40-60 days were 
isolated. The ganglia were fixed overnight in 4% PFA at 4
o
C and sectioned and stained them for 
MeCP2. Images showed very strong nuclear expression of MeCP2 in the DRG neurons (Fig. 6A, 
D). Expression could also be detected in some non-neuronal cells of glial and vascular lineage 
but at significantly lower levels (Fig. 6A, D). The sections were stained for peripherin, to 
localize the small diameter neurons, a subpopulation affected most strongly by BMP4/Smad1 
signaling in reproductive tract (Fig. 6B). All peripherin labeled cells show strong expression of 
MeCP2 (Fig. 6B,E,F). High MeCP2 expression was observed also in dissociated DRG neurons 
in culture. Peripherin positive neurons that express CGRP (subpopulation affected in vaginal 
plasticity) retained high levels of MeCP2 in vitro (Fig. 6G-J). Expression levels were low in non-
neuronal cells (Fig. 6I, J).   
BMP4 can regulate MeCP2 expression in peripheral sensory neurons 
MeCP2 is a global transcriptional repressor in neurons (Nan et al., 1997). 
Downregualtion of MeCP2 can therefore induce a global upregulation of gene expression, 
simultaneously turning on multiple genes (a phenomenon commonly observed preceding onset 
of axon regrowth) (Costigan et al., 2002). We tested whether BMP4 can regulate expression of 
MeCP2.  
99 
 
First, 50B11 cells were treated with 50ng/ml BMP4 17h after differentiation as described 
before and cell lysates were collected at 6h and 12h time points for mRNA isolation. 
Comparisons with qPCR showed that BMP4 treatment induced progressive decline in MeCP2 
mRNA levels at 6 and 12h (Fig. 7A). We then treated dissociated primary DRG cultures with 
BMP4 in a similar fashion and harvested total protein at 12h time point. BMP4 downregulated 
the expression of MeCP2 (Fig. 7B). 
MeCP2 knockdown in primary sensory neurons increased neurite outgrowth 
 We next asked whether change in levels of MeCP2 can affect outgrowth in sensory 
neurons. We tested whether MeCP2 knockdown impacts outgrowth in dissociated DRG neurons. 
A similar strategy was adopted as described before. Lentiviral shRNAs in the pLKO1 vector 
backbone were screened in 50B11 cells and one with 85% knockdown was selected and cloned 
into the EGFP expressing FG12 backbone. Dissociated neuronal cultures were plated with 
polybrene and an hour later infected with lentiviral supernatants carrying shRNA for scrambled 
control and MeCP2 knockdown respectively in two groups. At 48h after plating cells were fixed 
and stained for tubulin-βIII. Immunostaining for MeCP2 showed a marked reduction in the levels 
of thee protein in the EGFP stained cells containing knockdown, compared to adjacent 
uninfected neurons (Fig. 8). Neurite counting in EGFP expressing cells showed that MeCP2 
knockdown significantly decreased total outgrowth per neuron (Fig. 9A-C).  
BMP4 treatment failed to induce further upregulation of neurite outgrowth in MeCP2 
knocked down neurons 
 BMP4 treatment induced significant increase of outgrowth in the scrambled shRNA 
transduced neurons (Fig. 9C). However, treating MeCP2 knocked down cells with BMP4 
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produced no further increase of outgrowth compared to the untreated knocked down cells (Fig. 
9C).  
DISCUSSION 
In this study we described a potential mechanism by which BMP4 can induce axonal 
outgrowth in adult sensory neurons. By phosphorylating and activating the Smad1 transcription 
factor, BMP4 can elicit outgrowth not only under injury but also in uninjured axons under 
physiological conditions in vivo. Id2 is one of the downstream targets of pSmad1 (Miyazawa et 
al., 2002; Massague et al., 2005). We found that BMP4 substantially increases Id2 levels in the 
DRG neuronal cell line 50B11. Not only so, multiple other axon growth-promoting factors 
transiently increased Id2 levels.  
It is widely believed that regeneration recapitulates development, at least partially 
(Patodia and Raivich, 2012a). In the developing hippocampus or cerebral cortex, as a neuroblast 
matures into a neuron, escalating levels of Id2 induce vigorous axon extension. As maturation & 
target innervation is completed, growth ceases, and Id2 is rapidly degraded (Jackson, 2006; 
Lasorella et al., 2006). Id2 is a member of the helix-loop-helix (HLH) family of transcription 
factors which unlike the basic-HLH (b-HLH) transcription factors lack the basic domain (Powell 
and Jarman, 2008). Id2 can heterodimerize competitively with ubiquitously expressed bHLH TFs 
like E47 or E12, inhibiting the more tissue specific bHLH TFs (Aronheim et al., 1993; Powell 
and Jarman, 2008). In the mature neuron, heterodimers of pro-neural bHLH TFs (like NeuroD 
(s), neurogenins, Mash (s), etc.) and the non-tissue-specific bHLHs (like E47) bind to E-box 
elements of gene promoters of pro-neural factors and axon growth inhibitory factors that 
cumulatively induce maturation and resist further axon growth (Kabos et al., 2002; Jackson, 
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2006). But if Id2 levels are increased, it competes with bHLHs to bind and sequester E47. The 
resulting heterodimer fails to bind DNA and pro-neural bHLHs are ubiquitinylated and degraded 
(Iavarone and Lasorella, 2006; Powell and Jarman, 2008). This can potentially revert the neuron 
to a development-like state, thus activating outgrowth. This possibility is supported by the 
finding that overexpression of Id2 in 50B11 cells enhanced neurite outgrowth under basal 
conditions that was comparable to growth induced by trophic factor treatments, particularly 
BMP4. Furthermore, the downregulation of outgrowth in primary neurons with Id2 knockdown 
confirmed a role of the protein in adult axon outgrowth. 
The 50B11 cells provided a great deal of strength and convenience in the present study. It 
helped fulfill a serious dearth of cell lines for neurons, especially in the PNS. These cells not 
only retain most essential properties of the DRG neurons, but also more than 70-80% cells in 
culture differentiate to form neurons. This provided a much more enriched model to study 
neuronal expression of proteins like Id2 that are substantially present in most non-neuronal cells 
which comprise the majority population in a primary DRG culture. Furthermore, the cells 
provided an excellent tool to test and validate genetic modifications specifically in rat sensory 
neuron, especially in shRNA screening, which was hitherto unimaginable.  
 The findings that BMP4 increases Id2 levels in sensory neurons and Id2 can activate 
neurite growth, led us to hypothesize that BMP4 may induce outgrowth via Id2. However, while 
knockdown of Id2 inhibited outgrowth, it failed to fully abrogate BMP4’s effect. This raises the 
possibility that BMP4 may act further upstream in signaling cascade engaging multiple factors 
(and possibly few redundant ones) to bring about its effect cumulatively. Over nearly past two 
decades several studies have discovered multiple proteins and TFs to have critical regulatory 
impact on regenerative outgrowth following axon injury (Mechaly et al., 2006; Szpara et al., 
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2007). Significant contribution of TFs like ATF3, AP1s, CREB, STAT3 etc. towards successful 
regeneration have been well documented by both in vitro and in vivo evidences (Patodia and 
Raivich, 2012a). Genetic manipulations of these proteins have significantly downregulated 
growth following injury (Patodia and Raivich, 2012a).  Thus axon growth in vivo is a multi-
factorial event driven by the combined effect of all these different factors required to activate 
several critical processes including protein synthesis & transport, cytoskeletal dynamics and cell 
adhesion. 
It has been unclear whether similar signaling intermediates and TFs are involved in 
spontaneous outgrowth when there is no injury. Several active components generated at an injury 
site like cytokines, chemokines, growth factors etc. are essential to trigger the signaling 
intermediates of regenerative growth (Makwana and Raivich, 2005). However, what drives such 
multifactorial gene regulation in absence of the inflammatory cocktail has remained a baffling 
question. Downregulation of MeCP2 through Smad1 signaling offers a competent explanation. 
As a global regulator of gene expression, MeCP2 has strong influence on the neuronal 
transcriptome (Nan et al., 1997; Kaufmann et al., 2005; Guy et al., 2011). Discovered first as a 
methyl binding protein, MeCP2 is now well established as a strong regulator of neuronal gene 
expression (Meehan et al., 1992; Chandler et al., 1999; Kaufmann et al., 2005; Guy et al., 2011). 
Methylation of cytosine in the CpG dinucleotides is highly common in promoter regions of genes 
(Deaton and Bird, 2011). Binding to these methylated promoter regions MeCP2 helps recruit 
additional corepressors and Histone Deacetylases (HDACs), all of which repress gene expression 
(Nan et al., 1998b; Kaufmann et al., 2005). We found MeCP2 is extremely abundant in the 
sensory neuronal nuclei (like that of most CNS neurons) and thus a downregulation of MeCP2 
may remove repression and lead to a global gene activation. More recent studies show that the 
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high neuronal expression levels of MeCP2 almost equal a 1:1 ratio with histone octamers (Skene 
et al., 2010). This indicates a more generalized role of the protein in chromatin packaging (and 
global chromatin state) rather than methyl binding alone, and hence a stronger implication in 
global gene regulation. Although there are some candidate genes identified as targets of MeCP2 
regulation like FKBP5, sgk1 and sult1a1, the evolving consensus from findings in developing 
brain indicates that MeCP2 acts on a genome wide scale (often in activation-dependent manner) 
(Skene et al., 2010; Della Ragione et al., 2012; Tochiki et al., 2012). Whether in the sensory 
neuron MeCP2 downregulation invokes specific groups of genes to activate growth remains a 
question for future investigation using global gene expression analysis in MeCP2 knockdown.  
It is unknown whether BMP4 can regulate MeCP2 in non-neuronal cells. However, the 
phenotypic/functional outcomes of BMP4 treatment have dramatic cell fate-determining effects 
on several cell types (eg. stem cells, ES cells, bone cells, bone marrow progenitors etc.), which is 
associated with a global regulation of gene expression state. Thus, our findings open up the 
possibility of a new mechanism of downstream signaling from BMP4. Several questions 
including localization of BMP response elements (Smad binding regions) in MeCP2 promoter as 
evidence of direct vs. indirect regulation remain to be explored. 
MeCP2 is abundantly expressed in almost all neurons of brain. Expression is low in the 
embryo, but progressively increases in the neonate, reaching a final maximum in adult (Gonzales 
and LaSalle, 2010; Guy et al., 2011). Ever since the discovery of MeCP2 mutation as the cause 
of Rett’s Syndrome (an Autism Spectrum Disorder), a huge wealth of literature has accumulated 
on role of the protein in neurons of the developing as well as adult brain (Kaufmann et al., 2005). 
However, little is known about its expression or role in the PNS. While we found strong 
expression of the protein in DRG neurons and its critical role in outgrowth, very recent reports 
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also indicate a functional role in pain perception. In states of inflammatory pain induced by 
planter CFA injection, levels of MeCP2 decreased in both the spinal cord superficial horn and 
the DRG (Tochiki et al., 2012). Expression also decreased in DRG with a spared nerve injury 
(Tochiki et al., 2012). Since axotomy can initiate inflammation, is unclear whether axotomy or 
inflammation or both can cause MeCP2 downregulation. Furthermore, hyperinnervation at 
inflammation site has also been implicated as a cause for hyperalgesia. The downregulation of 
MeCP2 might also be possibly induced by axonal sprouting at the inflammation site. Further 
studies using knockout animal models should help find answers for many such questions.  
In humans, mutations of MeCP2 leads to Rett’s syndrome, an intellectual disability 
disorder categorized under the autism spectrum disorders (ASDs). Babies develop normally until 
about 18months of age, beyond which mental and locomotor disabilities ensue concurrently with 
increasing levels and activity of MeCP2 in brain (Kaufmann et al., 2005). However, much has 
been speculated about impact on peripheral neurons of these individuals. There is controversy 
about the validity of some earlier reports of altered sensitivity and pain perception due to less 
stringent data collection criteria. Intellectual disabilities of the subjects present a major challenge 
in effective data collection, which is often reliant on the care givers.  In a recent study that 
carefully avoided most of these pitfalls, it was revealed that there increased threshold and 
delayed response to pain stimuli in these patients. Both delayed and decreased response to 
injection, fall, trauma, burns was reported (Downs et al., 2010). Thus the findings of this study 
indicate that significant epigenetic regulations continue to occur in the adult sensory neuron and 
further research is needed for a complete understanding of its role in maintenance of the structure 
and function of the peripheral nerve.  
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FIGURES 
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Figure 1. Multiple growth factors induce Id2 upregulation in 50B11 cells. Relative expression of 
Id2 mRNA collected 6h after treatment of differentiated 50B11 cells with estrogen (E2, at 
20nM), nerve growth factor (NGF, at 50ng/ml), angiotensin II (AngII, at 100mM) and bone 
morphogenetic protein 4 (BMP4, at 50ng/ml). 
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Figure 2. Id2 overexpression induced increased neurite outgrowth in 50B11 cells. A. Full length 
Id2 cDNA was expressed in the pcDNA3 mammalian expression vector between the BamHI and 
XbaI restriction sites. B. Immunoblot showing Id2 overexpression in 50B11 cells transfected 
with vector in A. GAPDH was used as an internal control. (RNA level showed 5 fold increase) 
C. Differentiated 50B11 cells containing pcDNA3-Id2 overexpression showed increased neurite 
outgrowth than cells transfected with empty pcDNA3. D. Quantification shows that Id2 
overexpression increased total neurite outgrowth per neuron significantly compared to untreated 
as well as BMP4 treated control cells that are transfected with empty pcDNA3. (*p<0.05). 
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Figure 3.  
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Figure 3. Id2 knockdown in using lentiviral vector. A. The FG12 lentiviral vector. The shRNA 
against Id2 along with a CMV promoter was cloned between the XbaI and PacI sites. B. 
Lentiviral transduction of the Id2 shRNA induced a strong knockdown of Id2 in 50B11 cells. 
GAPDH was used as the internal control.  
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Figure 4. Id2 knockdown downregulated neurite outgrowth in primary DRG neurons. A. 
TubulinβIII staining in a control neuron transfected with scrambled shRNA. B. GFP labeling in 
the same neuron in A confirms viral transduction. C. A merge of A and B. D. TubulinβIII 
staining in a control neuron transfected with shRNA for Id2 knockdown. E. GFP labeling in the 
same neuron in D confirms viral transduction. F. Merge of D and E.G. Estimation of total neurite 
length per neuron showed that Id2 knock down significantly downregulated neurite outgrowth. 
(*p<0.05) 
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Figure 5. Quantification of neurite outgrowth in Id2 knock down primary DRG neurons in vitro 
following BMP4 treatment. In untreated groups, total neurite outgrowth per neuron was lower in 
the Id2 knock down cells compared to the scrambled shRNA transduced cells. After 24h 
following 50ng/ml BMP4 treatment, outgrowth significantly increased in the Id2 knock down 
neurons (*p<0.05).   
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Figure 6. MeCP2 is strongly expressed in adult DRG neurons. A. MeCP2 labeling in cross 
section of a L6 DRG. B. Peripherin counter staining in the same section. C. DAPI counter 
staining in the DRG section. D. Merge of A and C showing co-localization of MeCP2 in the 
neuronal nuclei. E. Merge of A and B shows that MeCP2 is strongly expressed in all peripherin 
positive neurons. F. Merge of A, B and C. G. A peripherin expressing adult DRG neuron in 
culture. H. The neuron in G also expresses CGRP. I. The neuron shows strong nuclear MeCP2 
expression in culture. J. DAPI counter-staining in the same visual field showing non-neuronal 
cells in the vicinity that express little or no MeCP2. 
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Figure 7. BMP4 downregulates MeCP2 expression in primary sensory neurons. A. Relative 
mRNA folds (compared to untreated control) of MeCP2 in 50B11 cells at 6h and 12h following 
BMP4 (50ng/ml) and NGF (50ng/ml) treatments. B. Representative immunoblot showing 
downregulation of MeCP2 protein in primary DRG neuronal culture 12h following treatment 
with 50ng/ml BMP4. GAPDH was used as an internal control. 
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Figure 8. 
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Figure 8. Lentiviral shRNA delivery effectively knocks down MeCP2 in primary sensory 
neurons of DRG in culture. A. GFP staining shows a DRG neuron in culture transduced with 
lentivirus, 48h following infection. B. MeCP2 staining in the same visual field shows high 
expression in an non-transduced neuron (arrow) and significantly reduced expression 
(arrowhead) in the virus transduced GFP-expressing neuron. C. Merge of A and B. Arrow shows 
the nucleus of the un-transduced neuron with high levels of MeCP2.  
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Figure 9. MeCP2 knockdown induces robust increase of neurite outgrowth in primary DRG 
neurons. A. Untreated neurons transduced with scrambled shRNA stained for tubulinβIII 
showing the basal level of outgrowth in culture. B. Untreated neuron transduced with MeCP2 
knockout shows enhanced outgrowth under basal conditions. C. Comparison of neurite 
outgrowth per neuron in following MeCP2 knockdown, with or without 50ng/ml BMP4 
treatment. MeCP2 knockdown significantly increases neurite outgrowth (MeCP KD) compared 
to scrambled transduced (FG12). BMP4 treatment of the scrambled group also increases 
outgrowth (FG12 BMP4). But BMP4 treatment fails to induce further increase in outgrowth in 
MeCP2 knock down (MeCP KD vs. MeCP KD BMP4). (*p<0.05). 
 
 
 
 
 
 
123 
 
 
 
 
 
 
 
 
 
Chapter 5. GENERAL DISCUSSION 
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Structural plasticity of peripheral nerves and its mechanisms have been studied for 
several years now. While much has been known about progress and mechanisms of regenerative 
outgrowth following injury, there was hardly any information about what drives spontaneous 
growth in adult axons in physiological states. The present study for the first time identifies 
BMP4 as a potential target-derived factor that can induce sensory outgrowth even in 
physiological conditions, by inducing a global transcriptional upregulation via genetic and 
epigenetic mechanisms. The female reproductive tract provided a highly tractable model system 
to study induction of plasticity under physiological conditions. And understanding of the 
mechanism provided information that can also be of high value in therapeutic design for 
potentiating axon growth as well as for ameliorating hyperinnervating pain conditions, 
particularly female pelvic pain syndromes.  
The persistent role of morphogenic growth factors in adult nervous system 
The present study demonstrates how growth factors that play critical role during 
embryonic morphogenesis (empirically referred to as morphogens) may have persistent effect on 
the mature nervous system. In the vagina, BMP4 not only persists beyond development to fulfill 
maturation, but continues to modulate innervation in the tissue through adult reproductive life 
(Chapter 2, (Bhattacherjee et al., 2013)). BMP4 expression is sustained in many other tissues in 
the adult organism like heart, lung, liver, pancreas, skin, bone and vascular endothelium that are 
richly innervated by peripheral axons (Pachori et al.; Sato et al., 1999; Sorescu et al., 2003; 
Frank et al., 2005; Hua and Sarvetnick, 2007; Maegdefrau et al., 2009; Le Bras et al., 2010; 
Pegorier et al., 2010; Do et al., 2012; Singh et al., 2012). Neuroplasticity has been reported in 
many of these organs under physiological or pathological conditions (Sternini and Brecha, 1986; 
Hasan et al., 2006; Cheng et al., 2010; Cui et al., 2010). From our current findings it is plausible 
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that BMP4 could be a potential regulator of plasticity in these cases. Future studies are required 
to confirm these possibilities. BMPs are also expressed by activated immune cells like 
macrophage (Champagne et al., 2002; Honda et al., 2006). Although inflammation can be 
associated with hyperinnervation, BMP signaling in immune cells has only been considered for 
an autocrine function for the cell’s fate transition so far (Hong et al., 2009; Millot et al., 2010; 
Chakrabarty et al., 2011). In light of the present study, concurrence of hyperinnervation and 
activated immune cell localization (which stain positive for BMP4, our preliminary studies) at 
inflammation sites warrant further investigation of BMP4’s role in inflammatory 
hyperinnervation as well.   
Like BMP4, there is a plethora of other morphogens including other BMP members, 
TGFβ members, Wnts, Frizzled, Sonic hedgehog, netrins (Tabata and Takei, 2004) that play 
critical roles in development of the nervous system (Rogers and Schier, 2011). In the embryo, 
concentration gradients of these morphogens set up along the path can translate navigating 
instruction for the progressing growth cone, leading to organization of the topographic mapping 
of innervation (Sanchez-Camacho et al., 2005; Miyashita et al., 2009; Rogers and Schier, 2011). 
Growing evidence indicate that many of these morphogens may regulate plasticity in the adult 
nervous system as well. Wnts, TGFβ, netrins have been shown to govern axon growth following 
injury (Zou, 2004; Park et al., 2007; Shim and Ming, 2010; Hellal et al., 2011). Expression of 
one or more of these proteins are also recorded in adult tissues like skin, bone, heart, lung, 
kidney, liver, skeletal muscle (Jakowlew et al., 1991; Zeisberg et al., 2005; Breitkopf et al., 
2006; Wetzel et al., 2006; Chen et al., 2010; Pachori et al., 2010; Ye et al., 2010; Kluk et al., 
2012; Singh et al., 2012). Many of these comprise sites for potential or active neuroplasticity 
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and/or functional changes like pain (Hasan et al., 2006; Miyashita et al., 2009; Chen et al., 2010; 
Ye et al., 2010; Chakrabarty et al., 2011; Lee et al., 2012).  
Interestingly, besides their independent action, many morphogens can collaborate with 
each other or different growth factors for effective and often tissue/cell specific outcomes. For 
example, while Wnts can partner with TGFβ in cellular adherence, tumorogenesis or metastasis,  
netrins collaborate with slit and wnt  to help axons choose their axis of migration (Attisano and 
Labbe, 2004; Bovolenta et al., 2008; Killeen and Sybingco, 2008; Lopez-Rios et al., 2008; 
Feigenson et al., 2011).  On the other hand, BMP signaling can collaborate with NGF to promote 
PC12 cell differentiation; with VEGF to stimulate endothelial cell migration and vasculogenesis; 
with Wnts to prevent oligodendrocyte maturation and induce cell lineage regulation, to mention a 
few (Deckers et al., 2002; Lonn et al., 2005; Holderfield and Hughes, 2008; Suzuki et al., 2008; 
Sharov et al., 2009; Feigenson et al., 2011; Trompouki et al., 2011; van Meeteren et al., 2012).  
However, in vagina BMP4 alone was sufficient to drive plasticity; additional support 
from neurotrophins like NGF did not seem additive or necessary for sensory sprouting. It is not 
known whether BMP4 plays a role in the genesis of innervation and axon distribution in the 
vagina during embryonic and early postnatal development; also, what the state of BMP4 
expression is before the animal begins cycling. Lack of suitable transgenic animal model is a 
major impediment. BMP4 null animals are lethal in utero as early as gastrulation (Gazzerro and 
Canalis, 2006) and lack of knowledge of unique promoters prevents generating conditional 
knockouts in vaginal submucosal smooth muscle. Due to their critical role in the embryo, it is a 
common problem with transgenic manipulations of most morphogens. Histological studies along 
developmental time lines coupled with in vivo viral gene modifications might help finding 
answers to some questions of these kinds. 
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Thus, while the present study reinstates the persistent importance of embryonic 
morphogens as growth factors in adult PNS, further research is needed to reveal the full 
repertoire of factors participating in adult neuroplasticity (for understanding of mechanisms and 
innovation in therapeutics). 
50B11 cells: A new tool for reliable and efficient assays in sensory neuronal research 
Studying cell signaling mechanisms in neurons has always been challenging owing to 
lack of suitable cell lines. In peripheral neurons, biochemical/signaling mechanisms have mostly 
been interpreted from experiments in non-neuronal cell lines or neuroblastomas and assessing 
phenotypic or structural outcomes have relied solely on PC12 line (adrenal medullar carcinoma, 
not even neuronally derived) (Greene and Tischler, 1976; Shastry et al., 2001). Some DRG 
neuronal lines generated intermittently in mouse or human have not only suffered from identity 
drifting in culture over multiple passages, but also failed to provide neuronal morphological 
phenotype (Platika et al., 1985a; Platika et al., 1985b; Wood et al., 1990; Fan et al., 1992; 
Raymon et al., 1999). The 50B11 cells for the first time presented both genotypic and phenotypic 
identity with primary sensory neurons, thus providing scope for more accurate results and 
interpretations. Owing to its complete neuron-like morphology and similar outgrowth dynamics, 
the cell signaling events due to treatments or genetic modifications directly translated to 
outgrowth changes and relevant interpretations could be drawn. For example, transcription 
factors like Smad1 and Id2 are not neuron specific, but rather widely prevalent with diverse 
effects on different cell types. Without the 50B11 line, several experiments performed in the 
present study would have therefore been difficult to interpret, or even conceive. Furthermore, the 
tools for genetic manipulations like overexpression or knockdown vectors could be validated 
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with much higher confidence in this rat cell line before transferring them to neurons in primary 
culture.  
Demonstrating majority of the characteristics of unmyelinated small diameter primary 
DRG neurons, the 50B11 cells have provided a powerful tool in study of sensory neuron biology 
spanning area like plasticity, degeneration, inflammation and pain. Apart from the typical 
neurotrophin and growth factor receptors the cells express key markers like TRPV1 and also 
show characteristic electrical properties (Chen et al., 2007a). However, further characterization 
demonstrating expression of other growth factor receptors, other TRP-channels, markers and ion 
channels would open opportunities of even broader application of this cell line as an assay 
system. Presently up to 80% cells in culture differentiate with forskolin treatment. Subcloning 
and selectively propagating a mixture of several highly differentiating subclones would be an 
ideal future goal for even further refinement of the assay. Genetic modifications can also be 
considered with constitutive (or inducible) overexpression of adenylate cyclase that can impart 
sustained differentiated neuronal morphology without a need for forskolin treatment. The cells 
hold great potential for generating overexpression and knockdown lines of various genes and 
studying their interactions. Cumulatively, these possibilities along with our findings put forward 
the 50B11 cells a powerful tool for high throughput studies that can bypass the inherent 
variability and heterogeneity of primary DRG cultures, giving sensory neuron research a whole 
new direction in future. 
BMP4 signaling via Smad1 can have a broad influence on gene expression 
BMP4 mediated sensory outgrowth in neurons is associated with the activation of the 
Smad1 transcription factor (Chapter 2, (Bhattacherjee et al., 2013)). With the help of 50B11 cells 
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we found that BMP4 can upregulate Id2 levels in DRG neurons (Chapter 4). While the Id family 
(Id1 to Id4) comprises a principal target of Smad1 (Miyazono, 1999; Massague et al., 2005), Id2 
is selectively increased in developing CNS neurons (in cortex, cerebellum, hippocampus) during 
the phase of active axon growth (Jackson, 2006; Lasorella et al., 2006). However, Id2 knockout 
mice show no major changes in brain histology or behavior, except for slight reductions in size 
of cortex and olfactory bulbs (Yokota et al., 2001). While overexpression of Id2 could potentiate 
in vitro outgrowth (Chapter 4) and adenoviral overexpression can improve regeneration 
following spinal cord injury (Yu et al., 2011), knocking down the protein failed to abrogate 
BMP4-mediated outgrowth. These cumulatively suggested a capability of Smad1 to induce 
outgrowth by regulating a broader umbrella of factors than Id2 alone. 
Growing evidence indicates that Smad1/5/8 is a powerful transcription factor that can 
regulate multiple other transcription factors downstream to modulate gene regulation rather than 
individual regulation of candidate genes (Massague et al., 2005; Fei et al., 2010). About 5% of 
the mouse genome (about 1500 genes) is committed to transcription factors (TFs), of which 1444 
are expressed at some stage in sensory neurons through development (Gray et al., 2004; Yusuf et 
al., 2012). While few TFs can act independently, most are parts of hierarchical patterns where 
one transcription factor can regulate multiple others downstream forming an organized network, 
to tightly control gene expression (Ocone and Sanguinetti, 2011). Tissue or cell-specific fine 
tuning at different levels of such hierarchies can generate unique gene expression patterns 
(Ocone and Sanguinetti, 2011). Smads are TFs located at the core of one of the most primitive 
signaling pathways, the TGFβ/BMP. Conserved from flies through vertebrates, the diverse 
effects of this signaling pathway on cellular growth, division, differentiation, morphology, 
metabolism etc. across different tissue types is evidence of the powerful and multifactorial 
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influence of Smad signaling (Massague et al., 2005). Thus Smads are master regulators of 
hierarchical transcriptional networks that can induce cell-specific effects acting via different 
downstream set of targets (Massague et al., 2005). 
Regulation of the ‘stemness’ (pluripotency) of stem cells by inducing Smad1/5/8 is a 
hallmark of the multifactorial effect of BMP4 (Zhang and Li, 2005). A recent study mapped 
Smad target genes genome wide in response to BMP signaling using embryonic stem (ES) cells 
as a model system. Promoter occupancy for Smad1/5 and Smad4 using ChIP sequencing 
(Chromatin Immunoprecipitation Sequencing) indicated regulation of multiple genes including a 
host of other transcription factors, cell surface proteins, ankyrins, ion channels, etc. (Fei et al., 
2010). However, as ES cells differentiated forming embryoid bodies, regulation of some of these 
factors changed differentially (Fei et al., 2010). Thus, while Smad1 is capable of simultaneously 
regulating multiple subcellular processes its action may be customized tissue specifically 
(Massague et al., 2005).  
Our findings showed that BMP4 can regulate MeCP2 in sensory neurons to regulate 
outgrowth (Chapter 4). As a global repressor of gene expression, downregulation of this protein 
may globally upregulate multiple genes with potential role in axon growth. Although expression 
of MeCP2 is highest in neurons as compared to any other cell in the body (Kishi and Macklis, 
2005), it remains to be evaluated whether BMP4 regulates this protein selectively in neurons. 
There is no precedence of BMP4 mediated regulation of MeCP2 in other cells. In neurons, 
Chromatin Immunoprecipitation experiments would be essential in future to confirm whether 
Smad1 directly regulates MeCP2 by binding its promoter or indirectly through other factor (s). 
Although knockdown of MeCP2 mimics the effect of BMP4 on neurite outgrowth, it remains to 
be determined whether MeCP2 (especially given the multifactorial effect of Smad1 in non-
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neuronal cells) is the only mediator delegated by BMP signaling to execute the effect on 
outgrowth. 
Interestingly, in CNS neurons outgrowth is arrested in a maturing neuroblast as Id2 levels 
begin declining (Jackson, 2006) and beyond this point as a neuroblast matures, MeCP2 levels 
increase (Kaufmann et al., 2005; Kishi and Macklis, 2005). These corroborate well with our 
findings in the sensory neuron showing that increase of Id2, but decrease of MeCP2 are 
associated with potentiation of outgrowth.  
MeCP2 and the epigenetic regulation of axon growth 
The downregulation of MeCP2 by BMP4 can induce epigenetic changes in the sensory 
neuron. In the past couple decade science has gained a vivid understanding of the epigenetic 
mechanisms in eukaryotic cells. Epigenetically, gene regulation is achieved by modifying 
chromatin (the nucleosomal histone-DNA complex) structurally and/or functionally, with no 
change in the genetic code encrypted in DNA (Bird, 2007; Kim et al., 2009). Footprints like 
cytosine methylation marks on DNA or modification of nucleosomal histone tails (lysine 
acetylation, methylation etc.) associated with particular genes form common landmarks for 
epigenetic modifiers to locate their binding target (Berger, 2002; Bird, 2007; Kim et al., 2009). 
These modifiers, usually proteins, bind and modify chromatin structure to alter accessibility of 
transcription factors or can further recruit additional co-activators or co-repressors (to the 
chromatin) to establish (or embellish) their influence (Bird, 2007; Kim et al., 2009). The MeCP2 
is one such modifier expressed heavily in neurons and bind methylated DNA with high affinity 
(Meehan et al., 1992; Guy et al., 2011). While selective Smad1/5 and 4 binding to large groups 
of genes associated with rich H3K27 trimethylated and H3K4 trimethylated bivalent histone H3 
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(i.e. trimethylation at 27
th
 and 4
th
 K or lysine residue, signature of active or repressive epigenetic 
marks respectively) has been demonstrated, direct regulation of epigenetic modifiers by BMP4 
has not been reported before (Fei et al., 2010). Thus our findings not only define a novel 
mechanism of neuronal outgrowth regulation, but also reveal a new mechanism of BMP4 
mediated epigenetic regulation. 
Heavy methylation of the cytosine in CpG dinucleotides of gene promoters are signatures 
of low-expressing or silenced genes (Miranda and Jones, 2007). MeCP2, through its methyl-
binding domain, binds to DNA in these regions across the genome and recruits Histone 
Deacetylases (HDACs) apart from other co-repressors and adaptor proteins (Nan et al., 1998b). 
The complex promotes deacetylation in tails of histones associated with the genes which allows 
the histones to wrap DNA more tightly resulting in repression/silencing (Nan et al., 1998b; Kishi 
and Macklis, 2005). Thus removing MeCP2 will potentiate gene expression globally, an outcome 
conducive for neuronal outgrowth.  
However, neuronal expression of MeCP2 is much higher than would be expected for 
selectively binding some methylated promoters alone. In sensory neurons too we detected levels 
comparable to CNS neurons. Some recent studies revealed that the protein not only expresses at 
stoichiometrically equal proportion to that of histone octamers, but can even compete with 
histone H1 to bind the linker DNA of nucleosome (Skene et al., 2010; Thambirajah et al., 2012). 
Diversifying MeCP2 actions even further, some reports show that it may participate in 
transcriptional activation in special cases (Chahrour et al., 2008). A very recent study 
documented MeCP2 binding to methyl-cytosine and 5-hydroxy methyl cytosine with equal 
affinity, even in the intragenic regions in DNA, specifically in neurons (Mellen et al., 2012). 
While there appears to be several confounding factors in describing the effects of MeCP2 on 
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neuronal transcriptome, the emerging consensus indicates that it likely regulates neuronal gene 
expression by globally altering chromatin state rather than specific target gene regulations 
(Skene et al., 2010; Della Ragione et al., 2012).  
Presence and appropriate regulation of MeCP2 levels is essential for neuronal process 
formation. While MeCP2 knockdown in adult sensory neurons boosted outgrowth (Chapter 4), 
the role of the protein in developing sensory neurons remain unknown. In CNS, which has been 
explored extensively for MeCP2 function, knockout resulted in increased cell density but 
reduced cell size and neurite growth leading to reduced thickness of neocortex in null mice 
(Kishi and Macklis, 2005). Overexpression of MeCP2 in embryonic cortical neurons in vitro as 
well as transgenic overexpression induced formation of longer neurites and axons (Jugloff et al., 
2005; Taylor and Doshi, 2012). Although MeCP2 knockdown in adult CNS neurons in vitro is 
deemed to be neuroprotective, no result on the effect on outgrowth has been reported (Russell et 
al., 2007; Dastidar et al., 2012). Therefore, while MeCP2 apparently plays contrasting roles in 
outgrowth in CNS and PNS, the studies conducted so far involved neurons from the two systems 
in different developmental stages (i.e. embryonic loss vs. adult knockdown respectively). Further 
research is essential to determine whether such differences are cell-type (i.e. CNS or PNS 
neuron) intrinsic or attributable to the cell’s developmental state. While outcomes in either 
direction would be groundbreaking in further understanding of MeCP2’s role in outgrowth, 
standing evidences substantiate that a fine balance of MeCP2 level is essential to maintain 
optimal transcription in a neuron initiating axon growth.  
Importantly, the functions performed by cortical neurons are different from those 
delegated by the primary sensory neurons. Accordingly, the sensory neurons that transduce 
information as primitive as pain, somatic sensation and kinesthesia are hardwired into the 
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circuit/function much early in development. On the contrary, the cortical neurons require 
adaptive inputs for substantial period in early life as it continues to make essential synaptic 
interconnections. In the developing brain the expression and influence of MeCP2 is low and 
gradually increases, peaking at about 12-18 months of age (in human) (Kaufmann et al., 2005; 
Kishi and Macklis, 2005; Guy et al., 2011). This time point coincides with the onset of 
psychomotor symptoms in patients of Rett’s syndrome who have MeCP2 mutation. Through 
these early days of postnatal development, MeCP2 is believed to undergo experience-dependent 
regulation and phosphorylation (Cohen et al., 2011) that potentially wires the long term 
connections of the neuron and prepares its transcriptional profile based upon the signals coming 
in from the environment. While comparable levels of MeCP2 expression is detected in adult 
sensory neurons, it remains unknown whether similar adaptive adjustments occur through early 
development, concurrently with the rise of sensory perceptions, or even potentially sustain 
through later life to define or refine sensory modalities. Supportive evidence from recent findings 
of elevated pain thresholds in Rett’s syndrome patients, decreased spinal and DRG MeCP2 in 
inflammatory pain and our findings on MeCP2 in plasticity give way to strong hypotheses for 
further studies in this direction (Downs et al., 2010; Tochiki et al., 2012). A complete study of 
the epigenetic landscape governing structure and function in the PNS holds promise not only for 
better mechanistic understanding of plasticity and perception, but also for advanced therapeutic 
design for disease states. 
Clinical Implications  
Our findings in the present study have valuable implications in several aspects of human 
disease. The results have direct and most substantial implication in women’s health. Pelvic pain 
syndromes like vulvodynia and vulvar vestibulitis are neurogenic pain syndromes associated 
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with genital CGRP hyperinnervation (Bohm-Starke et al., 1999; Tympanidis et al., 2003). These 
unmyelinated fibers not only contribute directly to transduction of nociceptive pain, they can also 
induce local CGRP release by antidromic conduction. CGRP induces vasodialation, immune cell 
infiltration, mast cell degranulation, protein extravasation etc. to bring about pain and 
hyperalgesia (Sato et al., 2000; Sandkuhler, 2009). Although local anti-inflammatory drugs are 
sometimes used as a treatment, observed benefits have been low with this approach in 
vulvodynia. Due to lack of understanding of the mechanism of hyperinnervation, surgical 
excision of the hyperinnervated vulvar tissue remained as the only option for permanent cure 
(Goetsch, 1996; Goetsch et al., 2010). We found that under low estrogen conditions BMP4 
induces selective proliferation of the CGRP fibers in the vaginal submucosa acting via the 
BMPR1A and BMPR2 receptor complex (Chapter 2, (Bhattacherjee et al., 2013)). On the basis 
of this, pharmacological, biologic, as well as vector mediated therapeutic strategies can be 
explored. 
Dorsomorphin is a recently discovered small molecule inhibitor of BMP signaling. It 
selectively inhibits BMP type I receptor and blocks BMP-mediated Smad1/5/8 phosphorylation. 
As a small molecule, dorsomorphin has high tissue penetration capability and bioavailability 
(Chapter 2, (Hao et al., 2008; Yu et al., 2008; Bhattacherjee et al., 2013)) making it a good 
candidate for local therapeutic application. The molecule is already being used in animal models 
in vitro and in vivo for regulation of stem cell fate, and can be explored for pharmacological 
inhibition of BMP4 mediated nerve sprouting in vulvodynia via both local and systemic delivery 
methods (Hao et al., 2008; Yu et al., 2008; Hao et al., 2010).  
While small molecules are still being explored largely in basic science laboratories, 
biologics like recombinant proteins are already in clinical application. For example recombinant 
136 
 
BMP2, BMP7 and the BMP-inhibitor noggin are approved and regularly used in orthopedic 
surgeries like bone reconstruction, spinal fusion and related procedures as slow release implants 
embedded in collagen matrix (Boden et al., 2002; Govender et al., 2002; Dimitriou and 
Giannoudis, 2005; Dimitriou et al., 2005). Local vulvar implantation of recombinant BMP 
antagonists can therefore be a promising direction to pursue in therapeutics. Furthermore, given 
our current findings that BMP4 can induce outgrowth in adult sensory axons, a similar strategy 
for recombinant BMP4 therapy might also be considered in neuropathies associated with 
degenerative sensory nerve loss.  
With rapid advances in gene therapy and success of some early clinical trials, 
recombinant protein therapy could be successfully replaced by local genetic modifications 
(Alexander et al., 2007; Tani et al., 2011). In the vulvo-vaginal tissue, that is easily accessible by 
non-invasive methods, local gene delivery can induce permanent cure by knocking down factors 
like BMP4 that induce hyperinnervation. While our present study showed highly successful gene 
delivery using viral techniques in rodent, both viral and chemical delivery methods can be 
explored in human for long term cure in future.    
Eventually, targeting the molecular machinery involved like Smad1 or MeCP2 might 
render the most control over adult sensory neuroplasticity in therapeutic development. However, 
more research is needed in this direction to first establish functional in vivo animal models. Since 
HDACs are essential partners for MeCP2 mediated gene repression, HDAC inhibitors (that have 
already entered clinical use) can also be explored as a pharmacological intervention to activate 
global gene expression for axon growth (Mei et al., 2004; Shabason et al., 2010).  
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